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2 ABBREVIATIONS 
 
%TBSA  Percentage of total body surface area. 
ABSI  Abbreviated burn severity score 
ACLF Acute-on-chronic liver failure 
ACTH Adenocorticotropic hormone, corticotropin 
AH  Adrenal hemorrhage 
AIS Abbreviated Injury Scale 
APACHE  Acute Physiology and Chronic Health Evaluation scores 
APASL Asian Pacific Association for the Study of Liver 
ARDS  Adult respiratory distress syndrome 
AKI Acute kidney injury 
bpm beats per minute 
CNS Central nervous system 
DHEA Dehydroepiandrostrerone 
DIC Disseminated intravascular coagulation 
DNAR Do not attempt resuscitation 
EMS Emergency medical service  
EOL End-of-Life 
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GCS Glasgow come scale 
HASB Hot air sauna burn 
HES Hydroxyethylstarch 
ICU Intensive care unit 
ISS Injury Severity Score  
LODS Logistic Organ Dysfunction System 
LOS   Length of stay 
MOF  Multiple organ failure 
MODS Multiple-Organ Dysfunction Score 
MPM   Mortality Prediction Model 
NPV Negative predictive value 
OD Organ dysfunction 
PPV Positive predictive value 
RIFLE risk, injury, failure, loss and end-stage kidney classification 
SAPS Simplified Acute Physiology Score  
SD  Standard deviation 
SIRS  Systemic inflammatory response syndrome 
SOFA Sequential Organ Failure Assessment 
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3 ABSTRACT 
 
To study fatal burns in the Helsinki Burn Center, sixteen years of data on burn 
deaths were collected and analyzed. These data included the early predicting 
factors obtained during pre-hospital care, clinical notes and autopsy reports. The 
study also classified clinically missed diagnosis revealed in autopsy and paid 
special interest in the prevalence of adrenal hemorrhage (AH) in non-surviving 
patients with burns. 
The study was carried out in two phases. The first phase included all deceased burn 
victims from the Helsinki Burn Center from 1995 to 2005. The clinical charts and 
medicolegal autopsy reports with organ specific changes were retrieved and 
compared. The data were evaluated by a team of two plastic surgeons specialized in 
burn care, an intensivist, and a pathologist. Causes of death, incidence of multiple 
organ failure (MOF) and AH and occurrence of diagnostic discrepancies were 
documented and analyzed. The second phase included burn patients with life-
threatening burns in the Helsinki Burn Center during 2006-2010. Pre-hospital 
patient records and clinical data collected during treatment were analyzed with 
reference to survival at 7 days, 30 days and 6 months. The patients were divided 
into two cohort groups and the data were analyzed in groups based on the presence 
or absence of a physician in the pre-hospital phase.  
The majority of burn victims die of untreatable burn injury (40%) or MOF (40%). 
Other causes of death are sporadic. Kidneys (100%) and liver (82%) were the 
organs most commonly affected in MOF. Lethal sepsis was never a sole cause of 
death, but always associated with MOF. Three MOF patients had bilateral adrenal 
hemorrhage, and four MOF patients had acute-on-chronic liver failure (ACLF).  
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Medicolegal autopsies revealed major diagnostic discrepancies in less than 6% of 
patients. These diagnostic discrepancies would have altered the clinical outcome or 
therapy had they been known in time. The most commonly missed diagnosis was 
pneumonia. 
Early accurate diagnosis and skilled therapy are essential in the prevention of 
MOF. Patients treated by paramedics compared with patients treated by pre-
hospital physicians were comparable with regard to age, gender and etiology of the 
injury. However, patients treated by pre-hospital physicians were more severely 
injured than patients treated by paramedics in terms of percentage of total body 
surface area (%TBSA) burned, injury severity score (ISS) and inhalation injuries. 
Patient’s age, %TBSA and ISS are significantly associated with short- and long-
term survival in burn patients. 
The study unambiguously reveals all the causes of death of the burn patients in the 
study period in the Helsinki Burn Center. The usefulness of autopsies in providing 
valuable clinical data for the treatment of burn patients is emphasized. The study 
also highlights a few missed diagnoses that may occur in burn patients and some 
early predicting factors of burn mortality are presented. The prevalence of AH was 
shown to be higher than previously estimated in non-surviving patients with burns. 
This study also reveals that the emergency medical system is able to recognize the 
situations and patients more likely to benefit from physician attendance.   
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4 INTRODUCTION 
 
Major burn injury is one of the most devastating forms of injury a person can 
sustain. Lives continue to be lost due to burn injuries despite improved patient care 
with early skin grafting, meticulous fluid resuscitation, and advanced antibiotic 
therapy (Garrison et al. 1995, Åkerlund et al. 2007). The exact cause of death after 
a burn trauma is not always evident. Nor do we yet understand all the specific 
events leading to the death of a burn patient. 
Some pre-hospital parameters have been shown to affect the trauma patient’s 
survival (Harris et al. 2012). However, only a few studies have focused on the 
effects of pre-hospital status and care on the mortality of burn patients. The early 
prognostic markers are significant in determining the care plan and in identifying 
patients potentially needing extra attention. 
Adrenal hemorrhage (AH) is a rare, yet potentially life-threatening event that 
occurs both in traumatic and in non-traumatic states (Rao 1995, Vella et al. 2001). 
Clinical manifestations can vary widely depending on the degree and rate of 
hemorrhage, as well as the amount of adrenal cortex compromised by hemorrhage. 
The etiology of adrenal insufficiency is most likely to be AH in the setting of burn 
patients (Sheridan et al. 1993). Although the condition is possibly fatal, prompt 
recognition and treatment will lead to good outcome (Nacul et al. 2002). The exact 
prevalence of AH in patients with burns is unknown, and none of the previous 
studies addressing AH following burn trauma are based on an autopsy database. 
The most common cause of death after a burn trauma in developed countries is 
death by multiple organ failure (MOF) (Sheridan et al. 1998, Miller et al. 2006, 
Bloemsma et al. 2008). Severe MOF and severe sepsis are both related to burn size, 
age, male sex, length of stay in intensive care, and duration of mechanical 
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ventilation (Cumming et al. 2001). Autopsies reveal the organ specific changes in 
MOF deaths, offering deeper understanding of the events leading to these deaths. 
Autopsies provide useful clinical data and serve as a quality control (Blosser et al. 
1998, Roosen et al. 2000, Silfvast et al. 2003). In Finland, medicolegal autopsies 
are required by law after a burn trauma death. This makes Finland especially 
suitable for cause of death studies, since cause of death is always ascertained. 
Autopsies occasionally reveal clinically missed diagnoses (Blosser et al.1998, Fish 
et al. 2000). The majority of the clinically missed diagnoses are minor and thus 
would have had no impact on patient care or survival had they been known in time 
(Fish et al. 2000). Major clinically missed diagnoses would have altered the 
therapy, possibly affecting survival if known in time (Blosser et al. 1998, Fish et al. 
2000, Roosen et al. 2000, Silfvast et al. 2003). Identifying and analyzing both 
major and minor clinically missed diagnoses are important in the recognition of the 
critical points in the care and in the attempt to improve care for burn patients. 
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5 REVIEW OF THE LITERATURE 
 
5.1 Skin 
 
Skin is one of the largest organs. With its subcutaneous tissue, it comprises 15-25% 
of body weight. Adult skin has 1.5-2m
2 
surface area. Skin has many functions; it 
protects underlying tissues, prevents vaporization of water, participates in body 
temperature regulation, and acts as a blood reservoir. It is an exocrine and a sense 
organ. It produces vitamin D. Skin also acts as an immunological organ due to the 
action of Langerhans cells, keratinocytes, lymphocytes and mastocytes. (Wysocki 
1999). 
 
5.2 Thermal injury 
 
A burn injury is caused by heat, electricity, corrosive chemical agent, friction or 
radiation. Exposure time and temperature affect the depth of a thermal injury 
(Moritz and Henriquez  1947). Burns are classified as first (I), second (II) and third 
(III) degree (Dupuytren 1832). Final estimation of burn degree is done 48 hours 
post trauma because burn wounds deepen during the first two days. (Jackson 1953). 
A first-degree burn is also referred to as a “superficial epidermal burn”. Superficial 
epidermal burns only involve epidermis, while deeper layers of the skin remain 
intact. In a first-degree burn the skin is dry, hyperaemic, and sore; there is no blister 
formation. These burns heal by regeneration of the epidermis from the basal layer. 
Healing occurs within one week without scaring. A sun burn is a typical first 
degree burn. (Jackson 1953).  
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Second-degree burns are typically caused by hot water and are always 
accompanied by blister formation. Second-degree burns are erythematous, sore, 
and moist. They are also called dermal partial thickness burns. These burns may be 
subclassified as superficial, mid-dermal, or deep. (Hettiaratchy and Papini 2004). 
Superficial dermal partial thickness burns affect the epidermis and the superficial 
part of the dermis (the papillary dermis). Most adnexal structures and vasculature 
remain intact. Exposure of the sensory nerves makes these burns painful. 
Superficial second degree burns may have delayed blister formation and they heal 
spontaneously by epithelialization from the skin appendages within two weeks. 
Superficial dermal burns may leave a hypo- or hyperpigmentation in the skin. 
(Hettiaratchy and Papini 2004, Evers et al. 2010) 
Mid-dermal partial thickness burns extend into the middle third of dermis with 
damaged but viable tissue at the base. Some of the nerve endings and capillaries are 
destroyed. Pain is milder than in superficial dermal burn and capillary refill is 
delayed. Blisters maybe present. The prognosis of healing and determination of 
appropriate treatment may be done 2-3 days after injury, when signs of healing or 
burn progression are established. Healing time is usually 14-21 days and scarring is 
possible. (Hettiaratchy and Papini 2004) 
Deep second-degree burns, also called deep partial thickness or deep dermal burns, 
involve a significant part of dermis, only deep adnexal structures may be intact. 
Deep dermal burns have immediate blistering, the skin peels off, and the exposed 
reticular dermis has no capillary refill, the circulation is sluggish and pain sensation 
is decreased. Dermal vascular plexus is extensively destroyed. Healing time is over 
21 days and hypertrophic scarring is likely. Deep second-degree burns are 
considered deep burns and require excision and skin grafting. A large, deep second-
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degree burn requires excision and skin grafting. (Jackson 1953, Hettiaratchy and 
Papini 2004, Evers et al. 2010). 
Third–degree burns are also known as full thickness burns. Flame usually causes a 
third-degree burn. The burn is deep, impacting all layers of skin and at worst also 
subcutaneous tissue and muscles. The injured area is dry, leathery, and without 
sensation as the sensory nerves are destroyed. There is no blister formation and no 
capillary refill. A third-degree burn does not heal spontaneously but always 
requires surgery. Scarring is inevitable. (Jackson 1953, Hettiaratchy and Papini 
2004).  
Tissue is harmed by heat release transmitter agents that cause capillary vessels to 
leak fluid into the interstitial cell space creating edema. Edema formation continues 
24 hours post-burn and causes deepening of the burn wound.  Large (over 20% of 
total body surface area (%TBSA)) burns cause generalized edema and thus 
hypovolemia. The capillary leak  diminishes circulating blood volume and may 
lead to hypovolemic shock without proper fluid replacement therapy (Lund  et al. 
1992, Latenser 2009, Evers et al. 2010). 
Hypermetabolism develops as a consequence of large burns. Energy expenditure, 
oxygen consumption and carbon dioxide production increase. This leads to 
increased ventilatory demand and minute ventilation increases. Hemodynamics is 
typically hyperdynamic; heart rate and cardiac output increase although 
occasionally myocardial depression may occur. As a sign of systemic inflammatory 
response hyperthermia may develop. Thermal injury also causes peroxidation of 
hepatocytes, tubular dysfunction in the kidneys, decreased blood flow to the bowel, 
pulmonary hypertension and edema. Catabolic reactions in fat and muscle tissue 
can be seen. (Latenser 2009). 
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5.3 Flame burns 
 
Flame burns typically occur at home (71%) to men (76%). Of burn admission to 
burn centers flame burns are the most common (47%).  (America Burn Association 
2013). Of hospital treated burns, flame injuries have the highest incidence of 
complications (18%) and the highest mortality (5.2% for men and 9.2% for 
women). The rate of complications increases with age. Patients younger than 20 
years have 11% incidence of complications as patients over 50 years have 22-28% 
incidence of complications. The most common complications are infections, 
particularly pneumonia, occurring at an incidence of 6% of all flame burn patients 
and representing 12% of all complications. (American Burn Association 2013). 
Smoke inhalation injury (13% of patients with flame burns) increases mortality 
from flame burns. Flame burn patients with smoke inhalation injury have eightfold 
higher risk of death than patients without smoke inhalation injury (24% vs 3%). 
The older the patient and larger the burn is, the worse the prognosis when smoke 
inhalation is present. Although only 24% of flame burn victims are female, the 
mortality is twofold higher for females. (American Burn Association 2013). 
 
5.4 Controversies in burn patient care 
 
5.4.1 On-scene care 
 
In burn traumas, some on-scene actions will reduce the mortality of the burn 
patients. These actions include supplying oxygen, starting  an intravenous line for 
analgesia and fluid resuscitation (Allison 2002, Cupera et al. 2002), as well as 
avoiding hypothermia (Singer et al. 2010).  
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Obtaining a victim’s medical history and detailed information about the burn injury 
and assessing possible concomitant injuries affect the prognosis and care given to 
burn victims (Allison and Porter 2004, Muehlberger et al. 2010). 
 
Other actions in on-scene care remain subjects of debate. These include the 
necessity and indication of intubation on site or during transportation (Mackie et al. 
2009, Eastman et al. 2010, Mackie et al.2011), the amount and quality of fluid 
resuscitation (Cancio et al. 2004, Endorf  and Gamelli 2007, Klein et al. 2007, 
Saffle 2007, Mackie et al. 2009, Mackie et al. 2011), a pre-hospital estimate of 
burn size and degree, burn wound coverage, and the speed of transport to the 
trauma center with or without a pre-hospital physician (Lerner and Moscati 2001, 
Mannova et al. 2002, Walker et al. 2005, Baez et al. 2006, Muehlberger et al. 
2010).  
 
5.4.2 Intubation 
 
Inhalation injury is diagnosed in 13% of flame injury patients (American Burn 
Association 2013). Inhalation injury causes airway swelling and obstruction. It is 
vital that patients with inhalation injuries are recognized and intubated at the site of 
the injury (Mackie et al. 2009, Eastman et al 2010). Sedation is needed when a 
patients is intubated. Sedation causes vasodilation and hypotension. In order to 
correct hypotension caused by sedation fluid resuscitation must be augmented 
(Cancio et al. 2004, Steinval et al. 2008, Feihl and Broccard 2009, Mackie et al. 
2009). Patients receiving excessive volumes of fluids are at increased risk of sepsis, 
adult respiratory distress syndrome (ARDS), pneumonia, multiple organ 
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dysfunction syndrome, and death (Klein et al. 2007). Intubation also increases the 
risk of pneumonia in burn patients (Mosier and Pham 2009). 
 
Inhalation injury is determined by bronchoscopy at the burn center (Eastman et al. 
2010). It is not possible to recognize the inhalation injury patients with 100% 
accuracy at the injury site (Mackie et al. 2009, Eastman et al. 2010). Intubating all 
burn patients is not recommended because of risks related to intubation (Mackie et 
al. 2009, Eastman et al. 2010, Mackie et al. 2011), however, not intubating a 
patient with inhalation injury may lead to airway obstruction (Eastman et al. 2010, 
Mackie et al. 2011). Therefore the subject of intubation on site is complex and 
hotly debated. Mackie et al. (2009) suggest that improving the diagnosis of 
inhalation injury would benefit the burn patients as unnecessary intubation could be 
avoided.  
 
5.4.3 Fluid resuscitation 
 
One cornerstone of modern burn care is an effective fluid resuscitation regimen; 
this has strongly improved patients survival (Åkerlund et al. 2007, Bak et al. 2009). 
The Parkland formula is one widely accepted and well-studied protocol for 
carrying out fluid resuscitation (Bak et al. 2009). However, there seems to be a 
trend towards providing increasing amounts of fluids, in excess of the Parkland 
recommendations, to avoid acute kidney injury during acute burn resuscitation in 
severely injured burn patients (Baxter 1981, Pruitt 2000). A number of studies have 
confirmed that exceeding the Parkland formula may have harmful effects and lead 
to increased mortality (Hobson et al. 2002, Klein et al. 2007). Over-resuscitation 
increases the risk of infectious complications, ARDS, abdominal compartment 
syndrome, and death (Hobson et al. 2002, Klein et al. 2007, Vaara et al. 2012). 
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Another issue is the use of colloids versus crystalloids for fluid resuscitation in 
burn patients. Fluid resuscitation with crystalloids frequently leads to 
hypoalbuminemia and it is debated whether this should be corrected by albumin 
supplementation (Atiyeh et al. 2012, Melinyshyn et al. 2013). 
   
Some studies conclude that patients resuscitated with colloids required less fluid 
than patients resuscitated with crystalloids (Endorf and Dries 2011, Atiyeh et al. 
2012), other studies have debunked this belief (Bayer et al. 2012, Perel and Roberts 
2012). Colloids can almost completely prevent edema in unburned tissues (Atiyeh 
et al. 2012). The outcome benefit of colloid use is still under discussion, however. 
Some studies deny that any outcome benefit has been proven so far (Atiyeh et al. 
2012, Perell and Roberts 2012, Melinyshyn et al. 2013, Perel et al. 2013), others 
advocate the use of albumin as it is not harmful and argue that it provides a 
mortality benefit (Endorf and Dries 2011, Atiyeh et al. 2012, Park et al. 2012). 
Albumin use is also associated with a reduced need for vasopressors and a shorter 
duration of mechanical ventilation in burn patients with burns to 20% or more of 
their total body surface area (Park et al. 2012). Although biological colloids such as 
albumin or fresh frozen plasma carry a risk of biological disease transmission, they 
are a better choice than synthetic colloids if colloids must be used (Atiyeh et al. 
2012). Atiyeh et al. (2012) claim fresh frozen plasma to be the best colloid solution 
available for burn patients as it diminishes the coagulopathy risk.  
 
Other studies have found the use of colloids harmful (James 2012). Colloid use 
may increase bleeding and mortality (Atiyeh et al. 2012, James 2012) and increase 
in lung edema (Atiyeh et al. 2012). Hydroxyethylstarch (HES) has proven to be an 
especially harmful colloid for critically ill patients. Large studies have proven HES 
to increase the risk of AKI, renal replacement therapy, acute liver injury, and death 
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compared to crystalloids (Brunkhorst et al. 2008, Myburgh et al. 2012, Perner et al. 
2012, Nisula et al. 2013). The European Medicines Agencys (EMA) 
Pharmacovigilance Risk Assessment Committee (PRAC) recommends that all HES 
products should be withdrawn from use (European Medicines Agency 2013). 
Gelatin is another synthetic colloid used. As with HES, gelatin also carries a risk of 
renal failure and is not suitable for critically ill ICU patients (Bayer et al. 2012). 
 
In 2008, the American Burn Association recommended that crystalloid-based 
resuscitation be used during the first 24 hours (Endorf and Dries 2011). As colloids 
are more expensive than crystalloids and do not improve survival, the use of 
colloids is not justified (Bayer et al. 2012, Perel and Roberts 2012, Perel et al. 
2013). 
 
5.5 ICU Scoring systems 
 
ICU scoring systems are created to evaluate the risk of death. Mean values of 
scoring systems can also be used in academic work to describe the general 
condition of patients. Several different scoring systems for ICU patients have been 
developed. Four major groups of ICU scorings systems exist: general risk-
prognostication scores, disease-specific risk-prognostication scores, trauma 
scoring, and organ failure (OD) scoring (Strand and Flaatten 2008). The scores 
should be validated for the specific populations in which they are to be used. Not 
all scores are validated for burn patients.  
General risk-prognostication systems are Acute Physiology and Chronic Health 
Evaluation (APACHE II-IV) scores (Knaus et al. 1985), mortality prediction model 
(MPM II), and Simplified Acute Physiology Score (SAPS II-III). APACHE II takes 
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in count 12, APACHE III 17 different physiologic variables, and APACHE IV 145 
of which most are admission diagnoses; all APACHE scoring systems perform well 
(Strand and Flaatten 2008). MPM II and SAPS II-III exclude burn patients. 
APACHE III and APACHE III-j (j being the tenth iteration of the APACHE III 
algorithm) scores (Knaus et al.1991) have been shown to correlate with outcomes 
for patients with burn injuries. (McNamee et al. 2010, Moore et al. 2010) 
Disease- and organ-specific prognostic scores are the Glasgow Coma Scale (GCS) 
(Jennett and Bond 1975) for the central nervous system, Ranson score for 
pancreatitis, Child–Pugh for liver failure and risk, injury, failure, loss and end-stage 
kidney (RIFLE) classification (Bellomo et al. 2004). These scores are used to 
quantify single-organ failure or a specific disease and are most often used outside 
the ICU as the scores are often not validated for ICU patients with concomitant 
organ failures (Strand and Flaatten 2008). GCS is included in other more complex 
scoring systems. Child-Pugh and Ranson are outdone by APCHE II and III scores. 
RIFLE has proven to be useful and reliable in the ICU as acute kidney failure is a 
frequent and important predictor of mortality in the ICU. (Strand and Flaatten 
2008). 
 
OD scoring systems include the Sequential Organ Failure Assessment (SOFA) 
(Vincent et al. 1996), Multiple-Organ Dysfunction Score (MODS) (Marshall et al. 
1995), and Logistic Organ Dysfunction System (LODS) (Le Gall et al. 1996). 
These scores are important as MOF is the leading cause of death for patients 
admitted to the ICU. As MOF is rather a continuum than an event these scores 
should be calculated on a daily basis. The SOFA and MODS scores take into 
account respiratory, renal, cardiovascular, CNS, coagulation (haematological for 
MODS), and hepatic failures giving a score from 0-4 to each organ, the higher 
number meaning more severe failure in SOFA scores. The sum of scores (SOFA) 
and individual scores (MODS) correlate to mortality. The SOFA scores may be 
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used in several ways, as organ specific scores, as the sum of scores on one single 
ICU day or the sum of worst scores during the ICU stay. In MODS, the worst 
scores of the whole ICU stay are recorded. The sum of these scores produce the 
final MODS score. LODS excludes burn patients. (Strand and Flaatten 2008). 
Table 1 represents the SOFA score. 
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Table 1. SOFA score. 
 
 
 
 
Score points 1 2 3 4 
Respiration 
PaO2/FiO2 
(mmHg) 
<400 <300 <200 
with respiratory 
support 
<100 with 
respiratory support 
 
Cardiovascular 
Mean Arterial 
Pressure (MAP) 
OR 
Administration 
of vasopressors 
 
MAP<70 
 
Dopamine 
<5 
or 
Dobutamine 
at any dose 
 
Dopamine >5 
OR 
Epinephrine< 
0.1 
OR 
Norepinephrine 
<0.1 
 
Dopamine >15 
OR  
Epinephrine >0.1 
OR 
Norepinephrine >0
.1 
 
Liver 
Bilirubin 
(μmg/L) 
>20 – 32 33 – 101 102 – 204 >204 
Renal system 
Creatinine 
μmol/L (or urine 
output) 
110 - 170 171 - 299 300 - 440 (or < 
500 ml/d) 
>440 (or < 200 
ml/d) 
Coagulation 
Platelets×10
3
/mcl < 150 < 100 < 50 < 20 
Nervous system 
Glasgow coma 
scale 
13 – 14 10 – 12 6 – 9 < 6 
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5.6 Burn scoring systems  
 
Repeated estimates of a burn injury’s severity are required to optimize patient care.  
The first estimates are done on the injury site and used as a precept to the level of 
the care the patient might need, i.e. nurse/paramedic, general practitioner, surgeon, 
or a team specialized in burn care.  
The following burns require treatment in units specialized in burn care: Large (over 
20 %TBSA) burns in adults. Patients requiring burn shock resuscitation. Burns 
involving face, hands, feet, genitalia, perineum, or major joints. Electrical and 
chemical burns. Inhalation injuries. Patients with concomitant trauma or disease. 
All deep partial thickness burns and full thickness burns, all circumferential burns. 
Burn injury in patients who will require special social, emotional, or rehabilitative 
intervention. (American Burn Association 2013, European Burns Association 
2013). 
In attempt to avoid unnecessary suffering, the chances for recovery are assessed.  
Patients with poor prognosis receive terminal care. For the estimation of patient’s 
prognosis, scoring systems have been developed. The simplest system is Baux, in 
which the sum of patients age and the %TBSA burned is calculated (Tobiasen et al. 
1982). A Baux of over 100 has indicated poor prognosis in the past, but as burn 
care has developed, flaws in the Baux system have emerged (Roberts et al. 2012). 
However, being a simple, easy to remember and fast to calculate, Baux rule still 
has a place in burn care (Jeng 2007, Roberts et al. 2012). As a general rule, one can 
assume that the higher the Baux value the worse the prognosis. 
Other more accurate, but more complex rules have also been used for calculation of 
a patient’s prognosis. The Abbreviated Burn Severity Index (ABSI) gives the 
patient score  according to sex, age, inhalation injury, full-thickness burn, 
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and %TBSA burned. As the sum of the score increases, the patient’s prognosis 
worsens. In general, a large full-thickness burn with inhalation injury in an older 
woman is the worst case scenario with maximum risk to survival. Table 2 presents 
the calculation of the ABSI and Table 3 presents the ABSI scores in relation to risk 
and survival (Tables 2 and 3) (Tobiasen et al. 1982, Andel et al. 2007, Forster et al. 
2011) 
 
Baux and ABSI both estimate true survival well. ABSI predicts death better than 
Baux. (Tobiasen et al. 1982). Despite advancements in burn care, ABSI has 
remained accurate in the prediction of burn patient mortality (Forster et al. 2011). 
The Baux score is a highly discriminatory prediction tool (i.e. patients that die have 
a higher Baux score than patients who survive) but shows very poor calibration (i.e. 
Baux predicted risk of death is much higher than the observed mortality). (Moore 
et al. 2010). 
 
For burn patients alone, one independent risk factor for death is percent full 
thickness surface area (FTSA) (Moore et al. 2010). The combined prediction model 
(APACHE III-j score/FTSA) shows similar discrimination but superior calibration 
(Moore et al. 2010). However, predicted risk of death using both variables, 
combining injury severity (percent FTSA) with physiological response (APACHE 
III-j score), is more accurate than either variable alone (Mooren et al. 2010). Baux 
index, SAPS II, and SOFA on admission to the ICU, infectious and respiratory 
complications, and time of first burn wound excision were found to have a 
significant predictive value for hospital mortality. The ICU survivors had 
significantly lower SAPS II, SOFA on admission, %TBSA burned, Baux index, 
presence of third degree burns, inhalation injury, infectious and respiratory 
complications, length of mechanical ventilation, time of first burn wound excision, 
and length of ICU stay than ICU non-survivor patients (Pavoni et al. 2010) 
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Table 2. The Abbreviated Burn Severity Index 
Variable Patient characteristic Score 
Sex Female 1 
 Male 0 
Age, years 0-20 1 
 21-40 2 
 41-60 3 
 61-80 4 
 81-100 5 
Inhalation injury  1 
Full-thickness burn  1 
%TBSA burned 1-10 1 
 11-20 2 
 21-30 3 
 31-40 4 
 41-50 5 
 51-60 6 
 61-70 7 
 71-80 8 
 81-90 9 
 91-100 10 
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Table 3. Abbreviated Burn Severity Index (ABSI) scores as related to risk and 
survival. 
Total Burn Score Threat to Life Probability of 
survival, % 
2-3 Very low >99 
4-5 Moderate 98 
6-7 Moderately severe 80-90 
8-9 Serious 50-70 
10-11 Severe 20-40 
12-13 Maximum <10 
 
 
5.7 Organ-specific perturbations of large burn injuries 
5.7.1 Adrenal glands 
The adrenal glands are stress hormone-secreting endocrine glands situated above 
the kidneys. They consist of two layers, the cortex and the medulla. The cortex 
produces mineralocorticoids, glucocorticoids, and androgens. The medulla 
produces catecholamines. (Baker 1997). 
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5.7.1.1 Mineralocorticoids 
The mineralocorticoid aldosterone is a hormone affecting the sodium 
(Na)/potassium (K) balance, increasing Na retention in the kidneys, sweat glands, 
salivary glands, and on the mucous membrane of the colon. Na retention increases 
osmolality of the blood plasma. The increased osmolality of plasma enhances the 
excretion of antidiuretic hormone, thus retaining water in the body and elevating 
blood pressure. Aldosterone excretion is controlled by the rennin-angiotensin-
aldosterone-system. (Funder 2010). 
5.7.1.2 Androgens 
Adenocorticotropic hormone (ACTH), a corticotropin extracted from the pituitary 
gland, regulates the release of glucocorticoids and androgens from the adrenal 
cortex. Dehydroepiandrostrerone (DHEA) is the most important androgen. DHEA 
is the precursor of sex hormones testosterone and estrogens. (Vaitukaitis et al. 
1969). 
5.7.1.3 Glucocorticoids 
The most important glucocorticoids are cortisone and corticosterone. 
Glucocorticoids have many effects; they increase the level of glycogen and glucose 
production in liver by activating glycogen synthase enzyme, reduce insulin effects 
in the liver and peripheral tissues, enhance lipolysis, catabolic reactions, and 
osteoporosis, suppress inflammatory reactions, and cause lymphopenia and 
leukocytosis. They also stimulate mineralocorticoid receptors, affecting body’s 
water balance. Glucocorticoids sensitize arteries to the effects of catecholamines; 
thus the lack of glucocorticoids manifests as poor reaction to vasopressors. (Munck 
and Guyre 1986). 
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5.7.1.4 Catecholamines 
Chromaffin cells in the adrenal medulla produce catecholamines, mainly adrenalin 
(epinephrine) and norepinephrine. Adrenalin production is stimulated by 
glucocorticoids, angiotensin II and cholinergic stimulation. Cholinergic stimulation 
causes adrenalin excretion through exocytosis. A variety of diverse signals, e.g. 
fear, hypoglycemia and trauma, lead to cholinergic stimulation. Catecholamines 
have three types of biological effects: cardiovascular, visceral, and metabolic. 
Alpha receptors (α1-2) are sensitive to adrenalin. α1 stimulation leads to contraction 
of smooth muscle tissue, α2 stimulation in the central nervous system (CNS) 
intensifies baroreceptor regulation of the vascular tonus.  Adrenalin also acts as β-
receptor agonist, regulating the hearts stroke volume and pulse (β1-receptors), and 
enlarging bronchial tubes and certain blood vessels (β2-receptors).  Adrenalin 
stimulates mainly β2-receptors. Catecholamines are the main hormones affecting 
the fight-or-flight reaction. (Eisenhofer et al. 2004). 
 
5.7.2 Adrenal hemorrhage 
 
5.7.2.1 Etiology of adrenal hemorrhage 
 
Adrenal hemorrhage is a rare, yet potentially life-threatening event that occurs in 
both traumatic and non-traumatic states (Rao 1995, Vella et al. 2001). Due to its 
rarity, the diagnosis is commonly made at autopsy. AH can occur in association 
with an acute stressful illness, e.g. infection/sepsis (Piccioli et al. 1994, Adem et al. 
2005) and multiple organ failure (MOF) (Jacobson et al. 2010), or event, e.g. 
surgery (Ries 1994). Other frequent associations include hemorrhagic diatheses, 
e.g. anticoagulant use and thrombocytopenia (Delhumeau et al. 1993), 
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thromboembolic disease, including antiphospholipid antibody syndrome (Caron et 
al. 1998), blunt trauma (Franque et al. 2004), and ACTH therapy (Kornbluth et al. 
1990). AH has also been linked to thermal injuries (Murphy et al. 1993, Deeb et al. 
2001) or the etiology may simply be idiopathic (Kamishirado et al. 2000, Imachi et 
al. 2010). Bilateral AH is a rare cause of acute adrenal failure, generally occurring 
in hospitalized patients who are septic, coagulopathic, or who have 
thromboembolic disorders (Nacul et al. 2002). 
 
5.7.2.2 Adrenal hemorrhage in burn patients 
 
Nacul et al. (2002) suggested that adrenal insufficiency after thermal injury might 
result in systemic inflammation, sepsis, thrombosis and coagulopathy with 
hemorrhage into the adrenal glands (Nacul et al. 2002).  Murphy et al. (1993) 
hypothesized the elevated corticosteroid secretion in thermal injuries severely 
stresses the adrenal glands. The combination of excessive adrenocorticotropic 
hormone stimulation and hemodynamic instability leads to AH (Murphy et al. 
1993). The etiology of adrenal insufficiency is most likely to be AH in the setting 
of burn patients (Sheridan et al. 1993), however the exact prevalence of AH in 
patients with burns is unknown. To the best of our knowledge, none of the studies 
addressing AH following burn trauma are based on an autopsy database.  
 
5.7.2.3 Clinical manifestations and treatment of adrenal hemorrhage 
Dysfunction of the adrenal cortex always causes Addison’s disease, regardless of 
the reason for the dysfunction. Acute adrenal insufficiency (Addisonian crisis) 
causes hypotension and electrolyte imbalance (Bouillon 2006). Clinical 
manifestations of AH can vary widely depending on the degree and rate of 
hemorrhage as well as on the amount of adrenal cortex compromised by 
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hemorrhage. An isolated focal unilateral adrenal hemorrhage may present 
subclinically, whereas massive bilateral AH may lead to rapid cardiovascular 
collapse and ultimately death, if not diagnosed early and treated appropriately. 
(Baker 1997). 
Addisonian crisis may occur when adrenal bleeding is bilateral (Rao et al. 1995); 
its management requires saline infusion and repeated administration of 
hydrocortisone (Coursin and Wood 2002). Long term management of Addison’s 
disease necessitates hydrocortisone and mineralocorticoid replacement therapy. 
With appropriate therapy, life expectancy is normal or related to underlying 
medical condition (Nacul et al. 2002). 
 
5.7.2.4 The role of adrenal function in   sepsis 
 
The cornerstones of treatment of septic shock are: early fluid resuscitation, blood 
cultures before antibiotic therapy, imaging studies performed promptly to confirm a 
potential source of infection, administration of broad-spectrum antimicrobials 
therapy, infection source control, and initial fluid resuscitation with crystalloid. 
(Dellinger et al. 2013). 
 
Intravenous hydrocortisone should be avoided in adult septic shock patients if 
adequate fluid resuscitation and vasopressor therapy are able to restore the 
hemodynamic stability in septic shock. In the absence of septic shock, 
corticosteroids should not be administered.  Hydrocortisone use is advocated only 
with suspected or proven adrenal insufficiency in children. 
Approximately 25% of children with septic shock have absolute adrenal 
insufficiency and death from absolute adrenal insufficiency and septic shock occurs 
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within 8 h of presentation. ACTH stimulation test has not been proven to be useful 
for the identification of adults with septic shock who should receive 
hydrocortisone. For the optimal duration of hydrocortisone therapy no 
recommendations can be given, therefore the aim should be to use the steroid 
therapy for as short as possible. (Dellinger et al. 2013). 
 
5.7.3 Acute-on-chronic liver failure 
 
The first articles about acute-on-chronic liver failure (ACLF) were published in 
1986 (Gimson et al. 1986); the subject has since been studied on a regular basis. 
However, ACLF has not been standardized for clinical or academic use until 
recently; the Asian Pacific Association for the Study of Liver (APASL) made 
consensus recommendations on acute-on-chronic liver failure. Based on these 
recommendations, ACLF is defined as:”Acute hepatic insult manifesting as 
jaundice and coagulopathy, complicated within 4 weeks by ascites and/or 
encephalopathy in patients with previously diagnosed or undiagnosed chronic liver 
disease.” (Sarin et al. 2008). 
The diagnosis of ACLF may also be done from histological liver samples. Two 
different types of histological patterns are seen in the liver of ACLF patients: 
“Pattern I: Hepatocyte ballooning, rosette formation, cellular cholestasis, variable 
interface activity, and fibrosis; and Pattern II: Marked ductular proliferation, 
coarse, inspissated bile plugs, foci of confluent necrosis/bridging necrosis, 
eosinophilic degeneration of hepatocytes, higher stage of fibrosis, and variable 
activity.” Nevertheless, the benefit of a histological sample must always be 
considered thoughtfully, as the patients are almost invariably critically ill. (Sarin et 
al. 2008). 
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5.7.3.1 Etiology of ACLF 
 
Chronic liver diseases in the Eastern world are mainly of infectious etiology, 
whereas in the Western world alcoholism predominates.  The same division is also 
seen for acute events from ACLF. Besides viruses and other infectious agents 
affecting the liver, an acute event might also be of non-infectious etiology: alcohol, 
drugs, autoimmune responses, surgical intervention, or variceal bleeding. 
Sometimes the etiology of hepatotoxic agents remains unknown (Sarin et al. 2008). 
Although the APASL did not reach consensus on sepsis as a cause of acute hepatic 
insults, there are articles in favor of this view (Duseja et al. 2010). A typical 
Western ACLF patient has alcohol cirrhosis and alcohol hepatitis simultaneously.  
 
5.7.3.2 Management and prognosis of ACLF 
 
Cytokines probably contribute to the development of ACLF, and thus, reduction of 
inflammatory cytokine responses might improve the prognosis of ACLF patients 
(Sarin et al. 2008). Additional circulating toxins may cause secondary liver damage 
and prevent liver regeneration in a patient with ACLF (Sarin et al. 2008).  
The use of liver support devices for treatment of ACLF has been extensively 
studied. Molecular adsorbent recirculating system (MARS) does not directly 
improve the prognosis of ACLF patients, but it may act as a bridge to 
transplantation, and it has been shown to improve encephalopathy in patients with 
ACLF. Antiviral therapy is beneficial to patients with hepatitis B-based ACLF. 
ACLF may be reversible if identified early and managed with aggressive critical 
care support. For patients showing no improvement on conservative therapy, liver 
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transplantation may be considered if the stringent criteria for transplantation are 
fulfilled. (Sarin et al. 2008). 
ACFL is a grave illness with high mortality. Most ACLF patients die of multiple 
organ failure (Garg et al. 2012). To the best of our knowledge, no previous studies 
on ACLF in burn patients exist. 
 
5.7.4 Kidneys 
 
Kidneys filter blood, extracting waste products, regulate electrolyte, acid-base, and 
water balances, and secrete endocrine hormones. 
Acute kidney injury (AKI) affects up to 30% of burn victims (Coca et al. 2007, 
Sabry et al. 2009, Mosier et al. 2010, Brusselaers et al. 2010). AKI worsens the 
prognosis of the burn patient, as the mortality rate raises to over 60% with this 
condition (Coca et al. 2007, Mosier et al. 2010). The pathophysiology of acute 
kidney injury is poorly understood, and thus, it is difficult to prevent. Prognostic 
factors for acute kidney injury seem to be high %TBSA burned, inhalation injury, 
and high creatine kinase levels (Davies et al. 1979, Davies et al. 1994, Holm et al. 
1999, Hu et al. 2012, Steward et al. 2012). Factors predicting survival from AKI 
are unknown.   
Factors related to acute kidney injury are myoglobinuria, significant hypotension, 
use of nephrotoxic antibiotics (aminoglycosides, vancomycin, amphotericin B), 
sepsis, and MOF (Hu et al. 2012, Monsier et al. 2010). Acute kidney injury may be 
corrected with renal replacement therapy (Stollwerck et al. 2011, Monsier et al. 
2010). Patients need renal replacement therapy if they have anuria or oliguria, 
hyperkalemia, anasarca, high serum creatinine, and high blood urea nitrogen.  
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AKI has two forms: early and late AKI. Early AKI begins within five days of the 
injury and is attributable to hypovolemia and systemic vasoconstriction or to 
myoglobinuria with damage to tubular cells (Holm et al. 1999, Davies et al. 1994). 
Nowadays, with effective fluid resuscitation, this form has become rarer.  The late 
AKI form develops later than five days post-trauma and has complex pathogenesis. 
Late AKI is related to sepsis and multiple organ failure and has higher mortality 
than in early AKI (Holm et al 1999, Coca et al. 2007, Monsier et al. 2010).  
 
5.8 Definition of MOF 
 
The definition of MOF ranges from altered function of organs to irreversible organ 
failures (Ferreira and Sakr 2011). Organ dysfunctions are mainly noted in the 
pulmonary, cardiovascular, renal, hepatic, hematologic, and central nervous 
systems (Marshall et al. 1995, Ferreira and Sakr  2011). Goris et al. in 1985, and 
later Lefering et al. in 2002, noted the gastrointestinal tract as one of the MOF 
organs. Goris et al. (1985) developed a system where organ dysfunction and organ 
failure were noted separately.  Lefering et al. (2002) found that gastrointestinal 
failure did not have impact on mortality and CNS damage was impossible to assess 
in most cases due to need for sedation for mechanical ventilation. Due to these 
findings, Lefering et al. (2002) suggested that GI and CNS failure should not be 
considered in MOF score assessments. 
 
By definition, multiple organ failure and systemic inflammatory response 
syndrome (SIRS) both affect at least three organs. This makes pinpointing the 
clinical diagnosis of death especially challenging. Severe MOF and severe sepsis 
are both related to burn size, age, and male sex. Both are related to the length of 
stay in intensive care and duration of mechanical ventilation (Cumming et al. 
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2001).  Sepsis is a clinical syndrome that complicates severe infection and is 
characterized by systemic inflammation and widespread tissue injury. MOF is a 
continuum, with increased physiological derangements in individual organs; it is a 
process rather than an event (American College of Chest Physicians 1992).  
 
5.9 Terminal care 
End-of-Life (EOL) categories are defined as cardiopulmonary resuscitation, brain 
death, withholding and, withdrawing life sustaining therapy, and active shortening 
of the dying process (Collins et al. 2006). Active shortening of the dying process is 
not legal in Finland and therefore not done to burn (or any other) patients. The 
most common form of EOL in Finland is the do not attempt resuscitation order 
(DNAR) which is done in accordance with patient and/or patients relatives. In burn 
patients, terminal care is withholding or withdrawing treatment and providing pain 
medication and/or sedation to make the patient comfortable. In an acute situation, 
the lines of treatment are not always evident. These patients receive ICU and active 
treatment, but may later have care withdrawn, as the patient’s treatment potential is 
reassessed. 
The decisions to transfer a patient to terminal care may be emotionally hard for the 
health care professionals (Wilkinson and Savulescu 2012). It is often considered 
easier to withhold treatment than to withdraw treatment, as it is sometimes morally 
seen as a question of “letting die” or “killing”. However Wilkinson and Savulescu 
(2012) argue, that these actions should be of the same value on the basis of the 
“Equivalence Thesis: Other things being equal, it is permissible to withdraw a 
medical treatment that a patient is receiving if it would have been permissible to 
withhold the same treatment (not already provided) and vice versa.” They suggest a 
trial period of active care to a wider range of patients to gain patient information 
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and to see the potential response to ICU care. Providing a trial period of ICU care 
also leads to a lower threshold for the withdrawal of care. 
 
5.10 Mortality 
 
The outcome of burn patients has improved over the past decades (Garrison et al. 
1995, Huss et al. 2001, Åkerlund et al. 2007, Krishnan et al. 2012). The overall 
mortality from burn injuries varies between 1.4% and 18% (Brusselaers et al. 
2010). Factors predicting increased mortality are contact burns, inhalation injury, 
age, burn size, and female gender (Barret et al. 1999, Raff et al. 1996, Brusselaers 
et al. 2010). Mortality is highest during the first week post-trauma. Previously up to 
75% of all burn deaths have occurred with one week of the trauma (Barret et al. 
1999). Individual organ failures affect the patient prognosis. Acute kidney injury 
raises the mortality to over 60% (Coca et al. 2007, Mosier et al. 2010). 
Careful fluid resuscitation and nutritional support, burn wound care and infection 
control, and pulmonary care are all attributable to better prognosis of the burn 
patient (Åkerlund et al 2007). 
 
5.11 Causes of death of burn patients 
 
The most common cause of death in patients with burns in developed countries is 
multiple organ failure (Sheridan et al. 1998, Bloemsma et al. 2008, Brusselaers et 
al. 2010, Krishnan et al. 2012). The American Burn Association’s registry of the 
causes of burn mortalities indicates that almost 50% of non-survivors died of organ 
failure (Miller et al. 2006). Sepsis is a serious and common consequence of burn 
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trauma (Wasserman 2001), although the number of patients dying of septicemia 
has declined (Bloemsma et al. 2008). Burns shock and inhalation injury are the 
main causes of early death (< 48h post-burn) (Brusselaers et al. 2010). 
 
Other causes of death are sporadic. The following causes of death in patients with 
burns have been reported: Adult respiratory distress syndrome (ARDS), 
pneumonia, liver failure, ischemic bowel, and toxic megacolon, cardiac arrest, and 
myocardial infarction (Krishnan et al. 2012). 
 
5.12 Value of autopsies 
 
The final medical operation provided for a deceased burn victim is autopsy.  
Autopsies reveal the true causes of death. The information gathered from autopsy 
reports serves as a quality control when estimating diagnosis missed in clinical 
practice. Autopsies accumulate knowledge for clinical and educational purposes in 
burn centers (Fish et al. 2000, Roosen et al. 2000, Podbregar et al. 2001, Ong et al. 
2002, Silfvast et al. 2003). 
 
A severe burn trauma leading to death is always caused by a crime, accident, or 
suicide. In Finland, medicolegal autopsies are obligatory by law when a death has 
been caused by a crime, accident, or suicide. Thus, all (100%) deceased burn 
victims undergo medicolegal autopsies. A state pathologist performs medicolegal 
autopsies at the Department of Forensic Medicine. No permission from next of kin 
is needed for medicolegal autopsies.  
 
Our autopsy rate (100%) for burn victims is exceptionally high. Studies in an adult 
intensive care unit (ICU) setting have had autopsy rates ranging from 33% to 89% 
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(Nadrous et al. 2003, Silfvast et al. 2003, Combes et al. 2004). An autopsy study in 
burn patients revealed that in 18% of the deaths, the causes were unknown and in 
4.5% the therapy would have been changed had the correct diagnosis been known 
(Fish et al. 2000). Over time, from 1919 to 1980, the frequency of unexpected 
autopsy findings has remained the same, only the nature of these findings has 
changed (Goldman 1984, Goldman et al. 1983). Autopsy remains an invaluable 
tool for retrospective diagnostic understanding of difficult cases, medical 
education, and quality assurance in burn units. 
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6 AIMS OF THE STUDY 
 
The purpose of this study was to scrutinize the burn deaths in Helsinki Burn Center 
by analyzing pre-hospital patient records, clinical data, and autopsy reports. 
 
Specific aims were as follows:  
 
1) To identify early factors during the pre-hospital care of burn patients 
associated with outcome. 
 
2) To examine the prevalence of adrenal hemorrhage in non-surviving patients 
with severe burns. 
 
3) To investigate the causes of death in patients with fatal burns and to specify 
irreversible organ dysfunctions leading to death. 
 
4) To compare premortem clinical diagnoses and autopsy findings in order to 
reveal and classify clinically important diagnoses that have remained 
undetected during intensive care of burn patients. 
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7 PATIENTS AND METHODS 
 
A retrospective chart review of adult burn patients was carried out in two stages.  
Patients for Studies I-III were retrieved for an 11-year period, from 1.1.1995 to 
31.12.2005. Patients for Study IV were retrieved for a 5-year period, from 1.1.2006 
to 21.12.2010. 
 
7.1 Studies I-III 
 
The Internal Review Board of the Helsinki University Hospital approved the study 
protocol (§133 / 15.8.2004 and §45 / 16.2.2012). For studies I-III, all burn-related 
admissions, deaths, and autopsy reports were identified from the hospital 
institutional database. All adult (age  ≥18 years) burn patients who had died in the 
Helsinki Burn Center, Helsinki University Hospital, Helsinki, Finland, between 
1.1.1995 and 31.12.2005 were included. 
 
The following data were obtained from the electronic medical record of the patients 
who had died in the Helsinki Burn Center and had had autopsies: age, gender, co-
morbidities, smoke inhalation injury, injury characteristics, %TBSA burned, length 
of hospital stay (LOS), and clinical cause of death. The autopsy diagnoses were 
obtained from the final autopsy reports. Prognostic indexes were calculated: Baux 
score (Tobiasen et al. 1982) and Abbreviated Burn Severity Index (ABSI) 
(Tobiasen et al. 1982, Andel et al. 2007).  
 
All patients underwent medicolegal autopsies. Pathologists macroscopically 
examined the bodies, and microscopic specimen of organs were obtained and 
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carefully analyzed. All findings, normal and abnormal, were documented. The 
autopsy diagnoses were obtained from the final autopsy reports. 
 
Data are presented as mean and range, except for number of organ failures, which 
is presented as median ± standard deviation (SD).  
 
Some patients were deemed palliative upon arrival to hospital. These patients 
received terminal care. The decision of terminal care was made by taking into 
account the patient’s age, previous illnesses, %TBSA burned, inhalation injury and 
concomitant traumas. The decision was made by a team of two plastic surgeons 
and an intensivist. Terminal care patients are included in the study population. 
 
7.1.1 Study I 
 
The objective of Study I was to compare pre-mortem clinical diagnoses and 
autopsy findings in order to reveal and classify clinically important diagnoses that 
have remained undetected during intensive care of burn patients. 
A team of two plastic surgeons specialized in burn care, an intensivist, and a 
pathologist evaluated all of the data collected. This team concluded each patient’s 
cause of death with organ specific changes. The team also compared clinical and 
the autopsy reports and classified the patients into different categories of autopsy 
discrepancies based on consensus. 
 
Discrepancies between clinical cause of death and autopsy findings were initially 
classified by Goldman et al. (1983), and modified later by Fish et al. (2000) to 
reflect the special character of burn injury. The classification system used in study I 
is presented in Table 4.  
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Table 4. Goldman and Fish classification for autopsy discrepancies in patients with 
burns. 
Major  
Class I Missed major diagnosis for which detection before death would have 
led to altered therapy or survival 
Class II Missed major diagnosis for which detection before death would not 
have led to altered therapy or survival because either no good therapy 
was available at the time or because patient had already received 
appropriate therapy, even though the diagnosis was unknown. 
Minor  
Class III Missed minor diagnosis that was attributable to the burn injury but 
would have had no impact on the treatment of the patient 
Class IV Missed minor diagnosis that was not attributable to the burn injury 
and would have had no impact on patient care 
Class V Complete agreement between pre-mortem clinical diagnosis and 
autopsy findings 
 
Special interest was paid to the amount of diagnostic discrepancies found, the year 
diagnostic discrepancies occurred, the specific diagnoses remained undetected 
clinically, the patient demographics and to the course of events leading to death.  
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7.1.2 Study II 
 
The purpose of Study II was to investigate the causes of death in patients with fatal 
burns and to specify irreversible organ dysfunctions leading to death. 
A team of two plastic surgeons specialized in burn care, an intensivist, and a 
pathologist evaluated all of the data collected. This team concluded each patient’s 
cause of death with organ specific changes by combining data from clinical charts 
and medicolegal autopsy reports.  
 
The cause of death in terminal care patients is referred to as “burn death,” unless 
autopsy showed other specific causes of death. 
 
MOF deaths were diagnosed by combining data from clinical charts and 
medicolegal autopsy reports.  In this study, in agreement with previous literature 
(Cumming et al. 2001), MOF was defined as the cause of death if a patient 
displayed three or more organ failures. Organ failures noted were central nervous 
system (CNS), pulmonary, cardiac, vasomotor, hematological, hepatic, 
gastrointestinal, renal, and adrenal. An organ failure could be either clinically 
indisputable, e.g. blood culture positive sepsis, or noted only at the autopsy, e.g. 
cellular damage.  
 
7.1.3 Study III 
 
The aim of Study III was to examine the prevalence of adrenal hemorrhage in non-
surviving patients with severe burns. 
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From the study population of all adult burn patients who had died in the Helsinki 
Burn Center during the study period, patients diagnosed with AH in clinical charts 
or at autopsy were sorted out. Particular attention was paid to the patient’s 
demographics, the prevalence of AH in non-surviving patients with severe burns, 
the course of events preceding their death and to their autopsy findings.   
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Flow diagram of patient distribution within studies I-III 
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7.2 Study IV 
 
The goal of Study IV was to identify early factors during the pre-hospital care of 
burn patients associated with outcome. 
Study IV is an observational retrospective cohort study. It was approved by the 
Ethical Committee of Helsinki University Central Hospital (§71 / 16.4.2007 and 
§152 / 28.9.2007). The inclusion criteria for this study were adult ( ≥ 18 years) 
patients suffering from burns treated at Töölö Hospital during a 5-year period 
between 1.1.2006 and 31.12.2010. The included patients had one or more of the 
following disorders: total body surface area (TBSA)  ≥20%, electric injury or hot 
air sauna burn, need for mechanical or assisted ventilation, risk of airway 
deterioration, need for vasoactive medication, delirium, and palliative care. Inter-
hospital transfers (referrals) were excluded. 
 
Patients with major burn injury from within a radius of approximately 100 km are 
transferred directly from the scene of the accident to Töölö Hospital. The 
emergency medical service (EMS) system is three-tiered, including one physician-
staffed ground unit in the city of Helsinki, and another physician-staffed unit 
equipped with an emergency medical helicopter for the rest of the area. Other units 
are staffed with paramedics of various training. The decision to include the 
physician-staffed units in the emergency response is made by dispatch centers. At 
the accident site, the paramedics can request reinforcements. In general, the 
guidelines conform to the approach presented by Allison and Porter (2004).  
 
The pre-hospital electronic and paper records were analyzed. Injuries were 
classified using the Abbreviated Injury Scale (AIS) (version 2005), AIS 
http://www.aams.org, for obtaining the Injury Severity Score, ISS (Baker et al. 
1974). Physiologic variables and interventions recorded during the pre-hospital 
50 
 
phase, in the emergency department, and in the burn unit were collected. The pre-
hospital estimate of the %TBSA burned and the suspicion of inhalation injury or 
smoke inhalation were recorded, as were the corresponding in-hospital final 
estimates of burn area and inhalation injury or smoke inhalation, as verified by 
bronchofiberoscopy. The pre-hospital estimates were made by the person with the 
highest training. The hospital estimates were made by a plastic surgeon specialized 
in burn care, and broncofiberoscopy was performed by an intensivist.  
 
The patients were divided into two groups, and the data were analyzed in groups, 
based on whether a physician was present or absent in the pre-hospital phase. For 
survival, outcome was calculated at 7 days, 30 days, and 6 months. Patients were 
divided into survivors and non-survivors according to their survival from the day of 
the accident. All causes of death during the follow-up period were included in the 
non-survivor group.  
 
For statistical analysis, SPSS 13.0 for Mac OS X was used. The categorical data 
were tested using the chi- square (Fisher’s exact) test and the continuous data using 
the Mann-Whitney U test. P-values ≤ 0.05 were considered statistically significant. 
 
To determine if the pre-hospital suspicion of inhalation injury or smoke inhalation 
predicts corresponding injury verified in the hospital, positive predictive values 
(PPVs) and negative predictive values (NPVs) were calculated. 
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Flow diagram of patient distribution between groups in Study IV 
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8 RESULTS 
8.1 Studies I-III 
 
The overall mortality rate between 1.1.1995 and 31.12.2005 was 5.4%. Of the 
admitted 1370 burn patients, 74 died in the Helsinki Burn Center from their burn 
injuries. However, due to three missing autopsy reports, the final study population 
consists of 71 patients for whom sufficient information was gained.  
 
After considering etiology, extent of burn injury, age, and comorbid conditions, an 
experienced team of burn specialists assessed 32 patients to have no hope of 
survival within 24 hours of the burn injury. These patients received terminal care.  
The cause of death for these patients was set as “burn death,” unless autopsy 
showed other specific causes of death. The remaining 39 patients received active 
treatment.  
 
All 71 patients underwent medicolegal autopsies. The two main causes of death 
were MOF and burn death, each accounting for 28 deaths. Together they accounted 
for 79% of the deaths. Other causes of death were scattered and comprised 21% of 
the deaths. Two-thirds of the patients were men and one-third women. Patients’ 
mean age was 57.5 (range 24–94) years. Distribution of number of patients, sex, 
and age was similar in the terminal care and active care groups.  
 
For all patients, the %TBSA burned varied from 4 to 100, mean 49.4. Terminal 
care patients had the highest %TBSA burned, with a mean of 64.5, whereas the 
active care group had a considerably lower mean of 37.0 %TBSA. The severity of 
injuries in the terminal care group was also reflected as higher Baux and ABSI 
values and in a shorter length of hospital stay. 
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The majority (87.3%) of the patients had flame burns. Hot air sauna burns (HASB) 
were found in 8.4%, scalds in 2.8%, and electric burns in 1.4% of patients. Two hot 
air sauna burns were in the terminal care group; otherwise, all patients in the 
terminal care group had flame injuries. One-third of patients in the active care 
group were alcoholics; in the terminal care group, alcoholism was diagnosed in half 
of the patients. 
 
Smoke inhalation injury was diagnosed in 23 (32.4%) patients. Terminal care 
group patients were diagnosed with smoke inhalation injury in 44% of cases; in the 
active care group smoke inhalation injury was diagnosed in 23% of the patients.  
Most (n=58, 82%) of the burns were classified as non-intentional, 10 (14%) were 
intentional (9 suicides and 1 assault), and three cases could not be classified. The 
terminal care group had more than twice as many intentional burns (n=7, 22%) as 
the active care group (n=3, 8%). 
 
Active care patients were operated on an average of 2.3 times (range 0-9 
operations).                                                                                                                                                                       
The majority 29 (74.4%) of patients underwent from one to three operations, two 
were operated upon four times, and one patient underwent five operations. Two 
patients had nine operations. Tracheostomies were performed on 15 (38.5%) 
patients. No operations were performed on the terminal care group, except for two 
patients who had tracheostomies on admission, before they were estimated to have 
no hope of survival. 
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8.2 Comparison of clinical diagnosis and autopsy findings in  
Study I 
 
The majority (n=61, 86%), of patients were classified as Class V, with a complete 
agreement between pre-mortem clinical diagnosis and autopsy findings. Altogether 
10 (14.1%) autopsies revealed previously undetected findings. There were six 
major discrepancies: four (5.6%) Class I and two (2.8%) Class II. The remaining 
four were classified as minor: three (4.2%) Class III and one (1.4%) Class IV. 
 
The missed diagnoses were five pneumonias, one pulmonary embolus, one ARDS, 
one myocardial infection, one severe hepatic cirrhosis, and one patient had kidney, 
liver and spleen necrosis.  
 
The missed diagnoses were rather evenly distributed over the years. All Class I 
mistakes occurred during different years. The highest number of diagnostic 
discrepancies was found in 1996, with three diagnostic discrepancies, one of each 
from Class I to Class III. 
 
8.2.1 Class I mistakes 
 
There were four major Class I diagnostic discrepancies. The missed major 
diagnoses were one pneumonia, one pulmonary embolus, one myocardial infarction 
and one kidney, liver, and spleen necrosis. All the patients with Class I missed 
diagnosis were in the active care group, comprising 10.3% of active care deaths 
and 5.6% of all burn deaths. Class I mistakes were made in years 1996, 2001, 2004, 
and 2005.  
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8.2.2 Class II mistakes 
 
Two Class II major diagnoses were missed: one severe hepatic cirrhosis and one 
adult respiratory distress syndrome. Both patients were in the active care group. 
Class II missed diagnoses formed 2.8% of all burn deaths and 5.1% of active care 
deaths. The diagnostic discrepancies occurred in 1996 and 1998. 
 
8.2.3 Class III mistakes 
 
Three minor mistakes categorized as Class III were found. All Class III missed 
diagnoses were found in the active care group, and they were all pneumonias. Class 
III mistakes occurred in 1996, 1999, and 2000. They consisted of 7.7% of active 
care deaths and 4.2% of all burn deaths.  
 
8.2.4 Class IV mistake 
 
There was only one diagnostic discrepancy in the terminal care group. It was an 
undiagnosed pneumonia in a severely burned older woman. She was in terminal 
care and survived only for one day. Autopsy showed that she died of pneumonia, 
although her clinical cause of death had been diagnosed as burn injury. Due to her 
short length of hospital stay, she must have had severe pneumonia upon arrival. 
This finding was classified as a Class IV mistake, with no effect on treatment and 
the diagnosis was not attributable to the burn. The Class IV mistake occurred in 
2001, and it comprised 1.4% of all burns deaths and 3.1% of terminal treatment 
deaths. 
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8.3 Multiple organ failure 
 
8.3.1 Multiple organ failure deaths 
 
The majority (82%) of the 28 MOF death patients were male. The mean age of the 
MOF cohort was 50.4 years and mean %TBSA burned 43.4%, yielding a mean 
Baux of 93.7%. All but two patients received active care. The mean ABSI score 
was 9.2 and mean length of hospital stay (LOS) 16.9 days. Table 5 presents the 
demographic of MOF patients (Table 5). 
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Table 5. Demographic data of the MOF patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
All 
patients 
 
 
All 
MOF 
deaths 
 
MOF 
without 
Sepsis 
 
 
MOF 
with 
sepsis 
 
MOF 
with 
ACLF 
 
MOF 
with AH 
 
Number of 
patients (M/F) 
 
 
71 (50/21) 
 
28 (23/5) 
 
15 (15/0) 
 
13 (8/5) 
 
4(3/1) 
 
3 (3/0) 
 
Age, years 
(range) 
 
 
57.5 (24-
94) 
 
50.4 (31-
81) 
 
48.5 (33-
66) 
 
52.3 (31-
81) 
 
47.75(36-
62) 
 
43.7 (31-
57) 
 
Care type 
  Active (%) 
  Terminal (%) 
 
 
 
39 (54.9) 
32 (45.1) 
 
 
26 (92.9) 
  2   (7.1) 
 
 
13 (86.7) 
  2 (13.3) 
 
 
13 (100) 
  0 (0) 
 
 
3 (75) 
1 (25) 
 
 
3 (100) 
0 (0) 
 
%TBSA  
(range) 
 
 
49.4 (4-
100) 
 
43.4 (7-
90) 
 
48.9 (7-90) 
 
37.0 (13-
65) 
 
33.9 (25-
38.5) 
 
45.3 (32-
65) 
 
Mechanism of 
trauma, (%) 
   
 Flame 
  Hot air   
  Hot water 
  Electric 
 
 
 
 
62 (87.3) 
  6   (8.4) 
  2   (2.8) 
  1   (1.4) 
 
 
 
24 (85.7) 
  2   (7.1) 
  1   (3.6) 
  1   (3.6) 
 
 
 
14 (93.3) 
   0  (0) 
   0  (0) 
   1  (6.7) 
 
 
 
10 (76.9) 
  2 (15.4) 
  1   (7.7) 
  0   (0) 
 
 
 
4 (100) 
0 (0) 
0 (0) 
0 (0) 
 
 
 
3 (100) 
0 (0) 
0 (0) 
0 (0) 
 
LOS, days  
(range) 
 
 
10.7 (1-98) 
 
16.9 (1-
98) 
 
13.1 (1-58) 
 
21.3 (5-
98) 
 
5.5 (1-9) 
 
10.3 (7-
16) 
 
Baux (range) 
 
 
105.6 (42-
152) 
 
93.7 (52-
138) 
 
97.4 (64-
138) 
 
89.4 (52-
125) 
 
81.6 (67-
98) 
 
89 (70-
108) 
 
ABSI (range) 
 
 
10.2 (4-15) 
 
9.2 (5-
13) 
 
9.5 (5-13) 
8 
8.8 (5-
12) 
 
8.5 (7-10) 
 
9 (7-12) 
 
Alcoholic (%) 
 
 
29 (40.8) 
 
10 (35.7) 
 
7 (46.7) 
 
3 (23.1) 
 
3 (75) 
 
0 (0) 
 
Reason of 
trauma, (%) 
 Accidental 
 Intentional 
 Undetermined 
 
 
58 (81.7) 
10 (14.1) 
  3   (4.2) 
 
 
24 (85.7) 
  3 (10.7) 
  1   (3.6) 
 
 
12 (80) 
  2 (13.3) 
  1 (6.7) 
 
 
12 (92.3) 
  1   (7.7) 
  0   (0) 
 
 
4 (100) 
0 (0) 
0 (0) 
 
 
3 (0) 
0 (0) 
0 (0) 
 
Tracheostomy, 
(%) 
 
 
17 (23.9) 
 
11 (39.3) 
 
6 (40) 
 
5 (38.5) 
 
2 (50) 
 
1 (33.3) 
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On average, MOF patients had 4 ± 1.62 organ failures (range 3-8). Table 6 presents 
the specific organ failures in the MOF death groups (Table 6). All MOF patients 
had acute renal failure, and 23 patients had liver damage. Four patients had both 
acute and chronic cirrhotic liver damage, i.e. acute-on-chronic liver failure.  
 
Lung injuries consisted of pneumonia and acute respiratory distress syndrome 
(ARDS). The majority (n=14) of the patients had only one type of lung injury. Four 
patients had ARDS and pneumonia simultaneously. Sepsis was found in 13 patients 
and disseminated intravascular coagulation (DIC) in three patients. CNS damage 
recorded comprised six anoxic/hypoxic brain damage/small hemorrhages, five 
edemas of the brain, and one edema of the brain with a recent cerebral infarction. 
 
As gastrointestinal complications, five patients had paralysis of the gastrointestinal 
track, four patients had acute pancreatitis, and one patient had inflammatory 
changes from the esophagus to the bowel accompanied by pancreatitis. Two 
patients presented with pericarditis, and two patients had myocardial infarction. 
Three patients had bilateral adrenal hemorrhage. 
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Table 6. Organs failures in patients who died of MOF, MOF without Sepsis, MOF 
with Sepsis, MOF with ACLF and MOF with AH. 
 
Organ All 
MOF 
patients 
MOF 
without 
sepsis 
MOF 
with 
Sepsis 
 
MOF 
with 
ACLF 
MOF 
with 
AH 
 N:o (%) N:o (%) N:o(%) N:o (%) N:o (%) 
Renal 28 (100) 15 (100) 13 (100) 4 (100) 3 (100) 
Hepatic 
     Acute 
     Cirrhosis 
     Cirrhosis+Acute 
23 (82.1) 
16 (57.1) 
3 (10.7) 
4  (14.3) 
11 (73.3) 
7 (46.7) 
2 (13.3) 
2 (13.3) 
12 (92.3) 
9 (69.2) 
1   (7.7) 
2 (15.4) 
4 (100) 
0    (0) 
0    (0) 
4 (100) 
1 (33.3) 
1 (33.3) 
0     (0) 
0     (0) 
Pulmonary 
     Pneumonia 
     ARDS 
     Pneumonia+ARDS 
18 (64.4) 
8 (28.6) 
6 (21.4) 
4 (13.3) 
8 (53.3) 
4 (26.7) 
3 (20.0) 
1   (6.7) 
10 (76.9) 
4  (30.8) 
3  (23.1) 
3  (23.1) 
3 (75) 
2 (50) 
1 (25) 
0   (0) 
3  (100) 
2 (66.7) 
1 (33.3) 
0     (0) 
Hematologic 
     Sepsis 
     DIC 
16 (57.1) 
13 (46.4) 
3 (10.7) 
3 (20) 
0   (0) 
3 (20) 
13 (100) 
13 (100) 
0     (0) 
3 (75) 
2 (50) 
1 (25) 
3 (100) 
3 (100) 
0     (0) 
Vasomotor 
     Tachycardia episodes 
     Bradycardia episodes 
15 (53.6) 
14 (50.0) 
1   (3.6) 
7 (46.7) 
7 (46.7) 
0      (0) 
8 (61.5) 
7 (53.8) 
1   (7.7) 
2 (50) 
2 (50) 
0   (0) 
1 (33.3) 
1 (33.3) 
0      (0) 
Central nervous system 12 (42.9) 5 (33.3) 7 (53.8) 1 (25) 0 (0) 
Gastrointestinal 
     Intestines 
     Pancreatitis 
     Intestines+Pancreatitis 
10 (35.7) 
5 (17.9) 
4 (14.3) 
1   (3.6) 
4 (26.7) 
3 (20.0) 
1   (6.7) 
0      (0) 
6 (46.2) 
2 (15.4) 
3 (23.1) 
1   (7.7) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
1 (33.3) 
0      (0) 
1 (33.3) 
0      (0) 
Cardiac 
     Infarct 
     Pericarditis 
4 (14.3) 
2   (7.1) 
2   (7.1) 
1 (6.7) 
1 (6.7) 
0    (0) 
3 (23.1) 
1   (7.7) 
2 (15.4) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
Adrenal 3 (10.7) 0    (0) 3 (23.1) 0 (0) 3 (100) 
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8.3.2 Multiple organ failure with or without sepsis (unpublished data) 
 
The MOF patients without sepsis were all male, and they had the worst burns of all 
MOF deaths or MOF deaths with sepsis. They had highest %TBSA, Baux, and 
ABSI values of all MOF deaths or MOF deaths with sepsis. They also had the more 
intentional and undetermined burn accidents than patients with MOF with sepsis.  
The patients with MOF without sepsis had a median of 3±0.6 (range 3-5) organ 
failures. This is the lowest number of organ failures per person of all MOF groups. 
MOF deaths with sepsis had the longest LOS values and most hot air sauna burns 
and scalds. On average they had 6±1.2 (range 3-8) organ failures, which is the most 
organ failures of all MOF groups. Besides sepsis, they had a high percentage of 
CNS, gastrointestinal, and cardiac damage. All adrenal hemorrhage patients were 
in this group. 
 
8.3.3 Multiple organ failure with acute-on-chronic liver failure (unpublished 
data) 
 
Four patients had acute-on-chronic liver failure. Three of them were male and one 
female. Their mean age was 47.8 (range 36-62) years. Three were in active care 
and one in terminal care.  They all suffered from accidental flame burns. Their 
mean %TBSA was 33.9, Baux 81.6, and ABSI 8.5. All had died of MOF.  
The patients with ACLF had on average 4±1.3 (range 4-5) organ failures. Besides 
ACLF, all had kidney failure. Two pneumonias and one ARDS were noted. In 
addition, two sepsis cases and one DIC were found. One CNS damage episode and 
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two tachycardia episodes were recorded. ACLF patients with MOF had no 
gastrointestinal, cardiac, or adrenal organ dysfunctions/failures. 
 
8.4 Adrenal hemorrhage 
 
Adrenal heamorrhage was found in four patients, comprising 5.6% of the study 
population. Three MOF patients had bilateral adrenal hemorrhage. They were all 
male with flame burns. Their mean age was 44 years. The mean %TBSA was 45, 
mean ABSI was 7. Only one patient had inhalation injury. All AH patients were in 
the active care group, and their mean survival was ten days. 
 
The patients with bilateral AH and MOF were diagnosed with 5±2.0 (range 4-6) 
organ failures. All three of these patients had sepsis, renal failure, and adrenal 
failure. Two patients had pneumonia and one had ARDS. One patient had 
tachycardia episodes, and one patient had pancreatitis. One acute hepatic failure 
was found. 
 
The clinical course of events leading to death was similar in the three patients; all 
had sepsis and clinical signs of renal and pulmonary failure, and all developed 
hypotension that was unresponsive to adequate fluid resuscitation and 
vasopressors. 
 
One patient had unilateral adrenal hemorrhage. He had hot air sauna burns and 
his %TBSA burned was 27. He was in the terminal care group, as he did not react 
to pain, nor did he regain consciousness, although the head CT scan was normal. 
He was constantly hypotensive and responded weakly to fluid resuscitation and 
vasopressive medication. He died within 24 hours of the admission. The 
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medicolegal autopsy revealed burn as the main cause of death. Other findings were 
unilateral adrenal hemorrhage, steatohepatitis, mild myofibrosis, four 
hemangiomas of the liver, and slight fibrosis of the renal cortex. 
 
8.5 Burn Deaths 
 
All 28 burn death patients received terminal care. The majority (68%) were male, 
with a mean age of 67.5 years. They had the highest %TBSA burned (mean 69.2), 
Baux (125.2), and ABSI scores (12.2) compared to MOF and other causes of death 
cohorts. Their mean length of hospital stay was 1.2 days. 
 
8.6 Other Causes of Death 
 
The other causes of death are sporadic, and this group was also the smallest (n=15) 
with the lowest %TBSA (23.7), Baux (91.2), and ABSI (8.2) values compared to 
MOF deaths or burn deaths. This cohort has the highest proportion of females 
(47%) and the oldest patients (mean 67.5 years). The majority (n=13) were in the 
active care regimen, and the mean length of hospital stay was 13.6 days. 
 
Causes of death were as follows: four pneumonias, two rhabdomyolysis, two 
cardiac arrhythmias, and two hypoxic brain damages. In addition, one of the each 
of the following was recorded: pulmonary embolism, coronary artery disease, 
failed tracheostomy, renal failure, embolus of the superior mesenteric artery 
followed by necrosis of the mesenterium. All thromboembolic complications were 
recorded in this cohort. Demographic data of patients in this group is presented in 
table 7 (Table 7). 
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Table 7. Demographic data of patients in group “Other causes of death”. 
 N:o 
(M/F
) 
Age 
(years
) 
(rang
e) 
%TBS
A 
(range) 
Baux 
(rang
e) 
ABSI 
(rang
e) 
LOS 
(rang
e) 
Mechanis
m of 
trauma 
All patients 15 
(8/7) 
67.5 
(38-
94) 
23.7     
(4-
62.5) 
91.2 
(42-
118) 
8.2    
(4-11) 
13.6   
(1-36) 
12 flame 
1 scald 
2 hot air 
Pneumonia 4 
(4/0) 
64.5 
(51-
88) 
27.1    
(6-
62.5) 
91.6 
(66-
118) 
7.8 (5-
11) 
11.8 
(4-20) 
3 flame 
1 scald 
Rhabdomyoly
sis 
2 
(2/0) 
57.5 
(38-
77) 
14.5    
(4-25) 
72   
(42-
102) 
6 (4-8) 18 (2-
34) 
1 flame 
1 hot air 
Cardiac 
arrhytmias 
2 
(0/2) 
68    
(60-
76) 
32     
(24-40) 
100 
(100-
100) 
9 (9-9) 18.5 
(10-
27) 
2 flame 
Hypoxic brain 
damage 
2 
(1/1) 
78.5 
(63-
94) 
10.5    
(4-17) 
89    
(80-
98) 
8 (8-8) 21     
(6-36) 
2 flame 
Pulmonary 
embolism 
1 
(0/1) 
62 15 77 8 15 1 flame 
Coronary 
artery disease 
1 
(0/1) 
84 23 107 10 15 1 flame 
Failed 
tracheostomy 
1 
(0/1) 
65 40 105 10 7 1 flame 
Renal failure 1 
(1/0) 
53 33 86 8 1 1 flame 
Embolus of 
the superior 
mesenteric 
artery 
1 
(0/1) 
82 22 104 10 4 1 hot air 
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8.7 Terminal care patients  
 
The majority of terminal care patients died of untreatable burn injury (n=28, 
87.5%), however, pathological findings indicated that four (12.5%) had causes of 
death other than untreatable burn injury. Two terminal care patients died of MOF, 
one died of renal failure, and one died of hypoxic brain damage. 
 
The terminal care patients with MOF were both male alcoholics with accidental 
flame burns of %TBSA 55 and 35. They were 56 and 63 years old. LOS was less 
than 24 hours, they both had inhalation injuries, but no tracheostomies. Baux 
values were 111 and 98, with corresponding ABSI values of 10 and 11.  They both 
had four organ failures. One patient had kidney failure, acute liver failure, ARDS 
and DIC, and the other had kidney failure, ACLF, DIC and CNS damage. 
(unpublished data). 
 
The terminal care patient who died of renal failure also had cirrhosis. He was a 53-
year-old alcoholic male with flame burns of %TBSA 33, Baux 86 and ABSI 8. His 
LOS was less than 24 hours. At autopsy, his renal cortex was found to be 
destroyed.  He had very deep burns through his muscles and his bleeding was 
uncontrollable upon arrival to hospital. Cirrhosis was suspected due to elevated 
hepatic values. (unpublished data) 
 
The terminal care patient who died of CNS damage was a 94-year-old female with 
flame burns of %TBSA 4, Baux 98, and ABSI 8. Her LOS was six days. She had 
inhalation injury. She was found unconsciousness in a cabin fire. She did not regain 
consciousness and had poor responses to pain stimulus. Her cause of death was 
CNS damage due carbon monoxide poisoning. (unpublished data) 
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8.8 Study IV 
 
8.8.1 All patients 
 
Between 1.1.2006 and 31.12.2010, altogether 67 patients with major burn injury 
were transported directly from the scene of the accident to the Helsinki Burn 
Center.  Our study population included all of these 67 patients with major burns. 
 
Of the 67 patients, the majority (60%) were men. The median age was 53 years. 
The etiology of the injury was predominantly flame (84%), followed by hot air 
sauna burn (HASB) (9%), electric injury (4.5%), and scald (3%). The final estimate 
of %TBSA was median 25. Inhalation injury was diagnosed in 42% of the patients.  
Median ISS score was 25. The first responding unit was on scene in a median of 10 
minutes. Time spent at the scene was a median of 37 minutes. The patients arrived 
at hospital 66 minutes after the first call to the dispatch center. 
 
An experienced team of burn specialists assessed 12 patients as having no hope of 
survival within 24 hours of the injury. These patients received terminal care. 
 
8.8.2 Patients treated by pre-hospital physicians (Group 1) 
 
The majority (73%) of the patients were treated by pre-hospital physicians (Group 
1). In this group, median %TBSA was 32 and ISS 25. Fifty-one percent had 
inhalation injury. On-scene pulse rate was a median of 110 bpm. On arrival to 
hospital, the systolic blood pressure was a median of 128 mmHg. The median pH 
was 7.28. Nearly all (96%) patients received supplemental oxygen, and the 
intubation rate was 63%. The median amount of intravenous solution given pre-
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hospital was 1.5 liters. In hospital, during the first 24 hours after injury, patients 
treated by pre-hospital physicians received a median of 13.5 liters of intravenous 
solutions.  
 
8.8.3 Patients treated by paramedics (Group 2) 
 
Paramedics treated 27% of the study population (Group 2). In the group, 
median %TBSA was 17 and the ISS 8. Sixteen percent had inhalation injury. On-
scene pulse rate was 91 bpm. On arrival to hospital, the systolic blood pressure was 
a median of 145 mmHg. Median pH was 7.34. Seventy-eight percent of the patients 
received supplemental oxygen. The intubation rate was 11%. The median amount 
of intravenous solution given pre-hospital was 0.5 liters. In hospital, during the first 
24 hours after injury, patients treated by paramedics received a median of 10.2 
liters of intravenous solutions. 
 
8.8.4 Parameters that did not reach statistical significance in the comparison 
between Group 1 and Group 2 
 
No significant difference between Groups 1 and 2 was observed in age, sex, 
etiology of injury, time elapsed to arrival on scene, time spent at scene, or time 
from emergency call to arrival to hospital. The first systolic blood pressure, first 
SpO2 and first Glasgow coma scale (GCS) were comparable. The pulse rate, SpO2, 
body temperature, paO2, paCO2, BE, or lactate did not differ significantly between 
the groups.  No statistical difference was found in the application of pain or 
vasoactive medication.  
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8.8.5 Survival for 7 days 
 
At seven days the survivors were considerably younger than the non-survivors (48 
vs. 62 years, p= 0.002). The non-survivors were more severely injured, with 
higher %TBSA (17 vs. 60, p=0.000), higher ISS values (9 vs. 33, p=0.000), and 
lower first GCS (15 vs. 13, p=0.028). On arrival to hospital the survivors’ SpO2 
was better (99 vs. 98, p=0.032), and pH was higher (7.31 vs. 7.27 p=0.049).The 
non-survivors were more often intubated (40% vs. 70%, p=0.034) and they 
received more intravenous solutions (11.5 vs. 26.0 liters, p=0.033) during the first 
24 hours. 
 
8.8.6 Survival for 30 days 
 
The 30-day survivors were younger than the 30-non-survivors (46 vs. 62 years, 
p=0.001). Females had higher mortality at 30 days than males; 29% of survivors 
were female and 58% of the non survivors were female, (p= 0.025). The non-
survivors were more severely injured than the survivors, with higher %TBSA (17 
vs. 55, p=0.000), and higher ISS values (9 vs. 17, p=0.001). First systolic blood 
pressure was higher in survivors than in non-survivors (132mmHg vs. 116mmHg, 
p=0.036). The non-survivors received more intravenous solutions during the first 
24 hours than the survivors (11.3 vs. 23.9 liters, p=0.010). The time spent on the 
scene was longer for survivors than non-survivors (50 minutes vs. 21 minutes, 
p=0.050). 
 
 
 
68 
 
8.8.7 Survival for 6 months 
 
Six-month survival: survivors were younger than the non-survivors (42 vs. 62 
years, p=0.000). A higher proportion of non-survivors were female; 26% of 
survivors were female, and 56% of non-survivors were female (p=0.014). Non-
survivors were more severely injured than survivors with higher %TBSA (17 vs. 
48, p=0.000), higher ISS values (9 vs. 17, p=0.000), and lower first GCS scores (15 
vs. 14, p=0.021). All (100%) non-survivors received supplemental oxygen, where 
as 87% of survivors received supplemental oxygen (p= 0.025). On arrival to 
hospital, survivors at six months had higher systolic blood pressure than non-
survivors (144 v. 116mmHg, p=0.025) and survivors had lower BE (-4.2 v. -7.5, 
p=0.048).  Non-survivors at six months received more intravenous solution than 
survivors (11.4 vs.20.4 liters, p=0.039). Pre-hospital supplemental oxygen was 
given to all (100%) patients who died at any of the survey points.  
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8.8.8 Factors not associated with survival at any of the survey points 
 
Etiology of the burn injury or inhalation injury was not associated with mortality. 
In pre-hospital treatment, the amount of intravenous solutions, pain medication, or 
vasoactive medication was not connected to survival at any of the survey points. 
 
In pre-hospital treatment, first pulse rate and first SpO2 % were not associated with 
mortality at any of the survey points. On arrival to hospital, pulse rate, body 
temperature, paO2, paCO2, and lactate were not connected to mortality at any of 
the survey points. Intubation at the emergency department did not affect survival.  
 
First spontaneous breathing rate, first body temperature, and GCS on arrival to 
hospital could not be calculated due to a large number of missing values in the 
hospital charts. 
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9 DISCUSSION 
 
This study provides a detailed overview of fatal burns. It reveals pre-hospital 
demographic parameters affecting mortality up to six months post-trauma. Further, 
it gives a comprehensive description of causes of death after burn trauma. We also 
identified some clinically important diagnoses missed during treatment. These 
diagnoses might have affected the treatment and outcome had they been known in 
time. 
 
The results highlight parameters that should make the clinician reassess the course 
of treatment, warning that the patient might be critically near death. For example, 
the probability of sepsis and continuum to MOF seems to increase with prolonged 
ICU stay (Cumming et al. 2001). Resuscitation unresponsive to vasopressors 
should raise the question of possible bilateral AH.  Patients’ age, %TBSA, and ISS 
affect the mortality up to six months post trauma. 
 
9.1 Missed diagnoses 
 
In 14.1% (n=10) of the study population, there was a discrepancy between the pre-
mortem clinical diagnosis and the autopsy finding. Each patient had only one 
missed diagnosis, no one had multiple diagnostic discrepancies. Of the diagnostic 
discrepancies, 8.5% were considered major and 5.6% would have altered the 
therapy or clinical outcome had they been known in time.  
 
Four (5.6%) patients had Class I, two (2.8%) had Class II, three (4.2%) had Class 
III, and one (1.4%) had Class IV missed diagnoses. One cardiovascular, seven 
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respiratory, and two gastrointestinal diagnostic discrepancies emerged. The most 
frequently missed diagnosis was pneumonia, seen in five autopsy findings. 
 
Of all patients, 86% were classified in to Class V, with no diagnostic discrepancies; 
Thus, 14% of patients had some level of diagnostic discrepancy. Fish et al. (2000) 
found a slightly higher number of diagnostic discrepancies in their study, 18% 
(Fish et al. 2000). The last two Class I mistakes were diagnosed in 2004 and 2005, 
emphasizing that despite diagnostic advances, some clinically important findings 
remain undetected, revealed only at autopsy. 
 
A full-time intensivist joined the burn team in fall 2001. The majority (80%) of the 
diagnostic discrepancies happened before this. Thus, knowledge of intensive care 
seems to help diagnose and treat conditions related to burn injury.  
 
9.2 Multiple organ failure 
 
In developed countries, MOF, SIRS, sepsis and other complications are the main 
causes of death in severely burned patients in the active care regimen (Saffle et 
al.1993, Cumming et al. 2001). Multiple organ failure is the leading cause of burn 
death in the developed countries (Bloemsma et al. 2008). Bloesmsma et al. (2008) 
published a MOF incidence of 65% among active care patients in their study 
(Bloemsma et al. 2008). The figure here is similar, 67% among active care patients. 
When taking all patients, terminal and active care, 40% died of MOF.    
 
The pathogenesis of MOF is not known, although it is thought to be a combination 
of ischemia/reperfusion, maldistribuition of microcirculatory blood flow, and 
imbalance between inflammatory response and immune function (Aikawa et al. 
1987,Cryer 2000, Ferreira and Sakr  2011). Divergent views exist regarding the 
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role of MOF in burn patients. Some articles support the view that MOF is the result 
of other contributing factors, such as sepsis (Fitzwater et al. 2003), while others see 
MOF as independent systemic manifestation of thermal injury itself (Cumming et 
al. 2001). I found two MOF patients who survived only one day and were 
diagnosed with MOF in the medicolegal autopsy. This seems to support the view 
that MOF is an independent manifestation of burn injury (Saffle et al. 1993, 
Dulhunty et al. 2008). 
 
The SOFA score (Vincent et al. 1996) is based on physiological values of 
respiration (PaO2/FiO2 (mmHg)), Cardiovascular (Mean Arterial Pressure (MAP) 
or Administration of vasopressors), liver (bilirubin (μmg/L)), renal system 
(Creatinine μmol/L (or urine output)), coagulation (platelets×103/mcl), and nervous 
system (Glasgow coma scale). The SOFA score is used to assess the development 
of multiple organ failure in ICU patients (Strand and Flaatten 2008), it also predicts 
in-hospital mortality (Pavoni et al. 2010). Previous studies have suggested that 
organ dysfunctions counted in MOF should be pulmonary, cardiovascular, renal, 
hepatic, and  hematologic (Lefering et al. 2002), while debated organ systems 
include the central nervous system (Marshall et al. 1995, Ferreira and Sakr  2011) 
and gastrointestinal system (Goris et al. 1985).  
 
The definition of MOF in this study is based on three or more organ failures noted 
clinically or as an autopsy finding. Our study has taken into account pulmonary, 
cardiovascular (vasomotor and cardiac), renal, hepatic, hematologic, and also CNS, 
gastrointestinal, and adrenal systems. MOF deaths were diagnosed by combining 
data from clinical charts and medicolegal autopsy reports. An organ failure could 
be either clinically indisputable, e.g. blood culture positive sepsis, or noted only at 
the autopsy, e.g. cellular damage. Our range of organ systems is wider than in 
previously published MOF definitions because we had detailed information from 
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medicolegal autopsies. For example adrenal failure is rarely noted clinically but 
clearly visible in the autopsy. However, our study does not segregate between 
organ failure and organ dysfunction. Some microscopical autopsy findings may 
have had little if any clinical relevance, e. g. small hemorrhages of the brain.   
 
Our study had some of the same organs as the SOFA score, but from a different 
point of view:  for example, our pulmonary organ failure could either be ARDS or 
pneumonia where SOFA has PaO2 values. SOFA focuses on physiological values 
regardless of the reason behind the deterioration of these values. Our study’s MOF 
diagnosis is based on clinical diagnoses regardless of the physiological values these 
diagnoses might demonstrate on a live patient. We also took into account some 
organ systems or diagnoses not noted at SOFA. These were adrenal, cardiac 
(pericarditis and infarct), and gastrointestinal. 
 
Our study provides valuable information on organ dysfunctions caused by MOF. 
We also reveal some clinical diagnoses behind these organ dysfunctions. Some 
gathered diagnoses have been revealed only at autopsy (e.g. adrenal haemorrhage), 
thus our findings serve as knowledge on clinical diagnoses behind burn deaths. Our 
definition of MOF is our own, and not used as such in any other studies, therefore 
direct comparison to other MOF studies might be biased.   
 
By definition, MOF affects several organs. Some studies have shown the lungs to 
be the most frequently affected organ in MOF (Sheridan et al. 1998, Bloemsma et 
al. 2008). In this study, however, the most frequently encountered organ failure in 
MOF deaths was renal failure, with an incidence of 100%. Renal failure is a serious 
complication among burn patients (Brusselaers et al. 2010, Mosier et al. 2010) with 
a mortality rate between 28 and 100% (Kim et al. 2003, Coca et al. 2007). 
Furthermore, early acute kidney injury is associated with early MOF in patients 
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with burns (Steinvall et al. 2008, Mosier et al. 2010). Only one patient in this study 
died of renal failure without MOF. This strong association between renal failure 
and MOF should serve as a warning sign. Patients with renal failure should be 
carefully monitored and treated to prevent the formation of MOF.  
 
9.3 Multiple organ failure and sepsis 
 
Less than half, 45%, of the MOF patients had sepsis. This finding is in line with the 
literature; Bloemsma et al. (2008) found sepsis to be the reasons for fatal clinical 
deterioration in 46% of MOF patients (Bloemsma et al. 2008). Sepsis was never 
found to be the sole cause of death. Here, sepsis seemed to promote the formation 
of organ failures or organ dysfunctions, as patients with sepsis had the highest 
number of organ dysfunctions. The patients dying of MOF with sepsis had longer 
lengths of hospital stay than patients dying of MOF without sepsis. Prolonged ICU 
stay increases the risk of infectious complications (Cumming et al. 2001).  In a 
clinical setting, signs of sepsis in burn patients should lead to more careful 
examination of possible organ dysfunctions to avoid the continuum to MOF. 
 
9.4 Multiple organ failure and acute-on-chronic liver failure 
 
Acute-on-chronic liver failure (ACLF) is a diagnosis where a chronic or long 
standing liver failure and an acute liver condition can be found simultaneously 
(Sarin et al. 2009). MOF is the cause of death for most ACLF patients, as the 
diagnosis easily leads to end-organ failures (Sarin et al. 2009). We found four 
patients with acute-on-chronic liver failure. All of our ACLF patients died of MOF.  
Half of the ACLF patients had sepsis and three-quarters were alcoholics. With 
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these patients, it is difficult to say which came first, the ACLF or MOF. They had 
the shortest LOS of all MOF patients and all burn patients. Naturally, pre-existing 
cirrhotic liver disease does not improve the chances of survival in a burn trauma. 
To the best of my knowledge, this is the first time that ACLF is associated with 
burns. 
 
9.5 Multiple organ failure and adrenal hemorrhage 
 
Autopsies revealed four (5.6%) patients with adrenal heamorrhage: Three patients 
(4.2%) with bilateral AH and one (1.4%) patient with unilateral AH. In the 
literature, 1.1% of deceased general hospital patients (Xarli et al. 1978) and up to 
15% of patients dying of shock have been demonstrated to have bilateral AH (Vella 
et al. 2001); however, these have not been burn patients. 
 
Reiff et al. (2007) found higher %TBSA and older age to be risk factors for acute 
adrenal insufficiency in severely burned patients in their case–control study (Reiff 
et al. 2007). Conversely, in our study, patients with bilateral AH were younger (44 
vs. 58 years), their %TBSA was lower (45 vs. 49), ABSI scores were lower (7 vs. 
10), and LOS was shorter (10 vs. 17 days) than other deceased burn patients. The 
rarity of AH patients imposes its own limitations on this comparison. 
 
The clinical course of events leading to death in bilateral AH patients was alike. 
One week after the burn, all were diagnosed with sepsis with a continuum to MOF, 
both of which are known etiologic factors for AH (Vella et al. 2001). They 
developed sudden hypotension unresponsive to vasopressors and fluid 
resuscitation. All three developed renal insufficiency. Despite adequate measures, 
all died. It seems that hypotension unresponsive to intravenous fluids or 
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vasopressors should always raise the question of the condition of patients’ adrenal 
glands and indicate CT scan or measurement of plasma cortisone in thermally 
injured patients. 
 
In the case of the unilateral AH, it is unclear whether the patient had AH prior to 
the injury, i.e. whether the hypotension leading to unconsciousness was the reason 
for prolonged exposure in the hot sauna air, or whether old age and large and deep 
thermal injury contributed to AH. Idiopathic AH cannot be ruled out in this case. 
 
9.6 Alcoholism 
 
Alcoholism is a predisposing factor for mortality in a burn patient (Raff et al. 
1996). Of all deceased patients in the 1995-2005 period, 41% were alcoholic. 
Alcoholic patients had more severe injuries and were more often in the terminal 
care group than non-alcoholic patients; the proportion of alcoholic patients in the 
terminal care group was 50%, but in the active care group only 33%. The 
relationship between alcohol and injury, including burns, is well-known 
(Macdonald et al. 2006, Thombs et al. 2007). Since the 1970s, “alcoholism” has 
been identified as a predisposing factor for burn injury (MacArthur and Moore 
1975). 
 
In patients with missed major diagnoses, there was a higher prevalence of chronic 
alcohol abuse than in other patients (67% vs. 29%). Only one patient’s diagnostic 
mistake was directly connected with alcohol abuse; the autopsy finding was 
terminal hepatic cirrhosis, which remained undetected during her care. 
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9.7 Burn complications 
 
Burn patients are especially prone to infectious complications. Major burn alters 
immune function, producing an imbalance between pro- and anti-inflammatory 
cytokine synthesis and increasing susceptibility to postburn infection and sepsis 
(Ayala et al. 2003, Zang et al. 2004). In patients with severe burns, with %TBSA 
exceeding 40, three-quarters of all deaths are related to sepsis from burn wound 
infection or other infectious complications and/or inhalation injury (Bang 2002). 
Pulmonary complications are common in burn patients with smoke inhalation 
injury. Further, prolonged intubation increases the risk for developing ventilator-
associated pneumonia (Santucci et al. 2003, Wahl et al. 2005). 
 
Burns are associated with multisystemic complications, even in otherwise healthy 
individuals. Age and number of pre-existing concomitant chronic diseases 
contribute to prolonged ICU care (Thombs et al. 2007). This study showed that 
patients with relatively low %TBSA can die. Four patients had %TBSA of less 
than 10. The causes of death of these patients were ARDS, pneumonia, hot air 
sauna burn with rhabdomyolysis, and smoke inhalation injury. The %TBSAs were 
7, 6, 4, and 4, respectively. The latter two patients’ care was discontinued as futile. 
 
9.8 Inhalation injury 
 
Outcome from severe burn is associated with three major risk factors for death: age  
≥60 years, %TBSA ≥40%, and presence of inhalation injury (Ryan et al. 1998, 
Brusselaers et al. 2005, Andel et al. 2007). 
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During 1995 to 2005, inhalation injury was diagnosed in 23 (32%) of this study’s 
patients. Nine (39%) of the patients received active care. This highlights the 
severity of inhalation injury, as of the deceased patients, 32% had inhalation 
injuries and 61% of the patients having inhalation injury on arrival were deemed 
palliative.  
 
During 2006 to 2010, altogether 28 patients were diagnosed with inhalation injury. 
Pre-hospital physicians treated 25 and paramedics only three of these inhalation 
injury patients.  As inhalation injury poses a threat to airways and often demands 
sedation and intubation, this strong division of patients seems appropriate and 
shows that the EMS system is able to recognize patients in need of a pre-hospital 
physician. Suspicion of inhalation injury in the field was accurate, PPV 0.86 and 
NPV 0.92. Contrary to the literature (Ryan et al. 1998, Brusselaers et al. 2005, 
Andel et al. 2007), in our study inhalation injury did not have an influence on 
survival. 
 
Only one of the AH patients presented with smoke inhalation injury; thus, based on 
this small-scale study, smoke inhalation injury appears not to predispose to AH. 
 
9.9 Hot air sauna burns 
 
Hot air sauna burns (HASBs) resulting in rhabdomyolysis are rare but severe 
injuries (Koski et al. 2005). Hot air sauna burns develop due to prolonged 
immobility or loss of consciousness in the hot sauna air (Papp 2002). Full-thickness 
skin damage with deeper tissue destruction affecting the muscles is typically seen 
in these burns (Papp 2002, Koski et al. 2005, Ghods et al. 2008). 
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During the first study period from 1995 to 2005, six patients had HASBs. Two 
received terminal care and four were in the active care group. Two of the active 
care HASB patients would have received terminal care had their proper diagnoses 
been known in time. These were classified as Class I missed diagnoses. Their 
autopsy findings were myocardial infarction and necrosis of the abdominal organs. 
These findings highlight two facts: First, the main cause of unconsciousness in the 
sauna sometimes remains unknown (e.g. heart attack/cerebral 
infarction/intoxication and dehydration) and might have a considerable impact on 
treatment. Second, it is often impossible to estimate the time that the patient has 
been exposed to hot air. 
 
During the second study period (2006-2010), there were 15 HASB patients. In this 
study, the mechanism of burn trauma had no influence on survival. 
 
9.10 Fluid resuscitation 
 
In Study IV, in both the physician- and paramedic-treated groups, patients were 
resuscitated in excess of the Parkland recommendations; 185% and 169%, 
respectively. This confirms earlier findings of “fluid creep”, a tendency to 
resuscitate patients over Parkland formula (Baxter 1981, Pruitt 2000).  
 
During the first 24 hours survivors received approximately 11 liters of intravenous 
solutions. Non-survivors received more than twice as much intravenous solution, 
roughly 24 liters. The severity of the condition of patients included in this study 
may in part explain the excessive fluid resuscitation. Vigorous measures were taken 
in an attempt to rescue these patients, including substantial fluid resuscitation to 
keep blood pressure and kidney function at acceptable levels. Abundant 
resuscitation was connected to mortality up to 30 days and 6 months post trauma. 
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This confirms previous findings (Hobson et al. 2002, Klein et al. 2007) that over-
resuscitation during the first 24 hours has long term effects.  
 
9.11 Mortality 
 
The mortality rate in the 11-year study period from 1995 to 2005 was 5.4%. The 
second study period from 2006 to 2012 showed that age, %TBSA, and ISS scores 
affected the mortality most. These findings are in line with previous literature from 
other European study centers (Ryan et al. 1998, Brusselaers et al. 2005, Andel et al. 
2007, Gravante et al. 2007).  
 
The majority (67%) of the non-survivors during 2006-2011 died within seven days 
of the injury, and 40% of the non-survivors received terminal care. The study from 
1995 to 2005 confirmed similar numbers; 45% of the non-surviving burn patients 
were estimated to have no hope of survival within 24 hours after admission to the 
hospital. This emphasizes the potential lethality of a major burn injury. A 
considerable proportion of the patients are beyond help, no matter how advanced 
the pre-hospital and hospital care is. 
 
9.12 Terminal Care 
 
Altogether 44 patients were considered to have no hope of survival within 24 hours 
of admission. During 1995-2005 the terminal care patient had besides more smoke 
inhalation injuries also higher %TBSA (65 vs. 37) than patients who received 
active care. There were considerably more intentional burns in the terminal care 
group than in the active care group. Moore et al. (2010) found non-survivors to be 
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older, more severely burned, and with a higher incidence of deliberate self-harm 
than the survivors (Moore et al. 2010).  
 
The decision to transfer a patient from active care to terminal care is always 
difficult. The patient’s medical history and present condition, wishes of the patient 
and family members, and the patient’s prognosis based on the experience of the 
burn team and literature affect this decision. Diagnostic discrepancies may result in 
incorrect interpretation of a patient’s prognosis and present condition; thus, the 
patient may receive inappropriate care for his true condition. 
 
Interestingly, in the terminal care group only one patient was recorded as having a 
discrepancy between the clinical cause of death and autopsy findings. Moreover, 
this diagnostic discrepancy was classified as Class IV, i.e. it had no impact on 
patient care. We expected that in this group there would have been autopsy 
findings, such as myocardial infarction or cerebral infarction, that might have led to 
severe burn injury as a result of unconsciousness. The lack of this finding might be 
explained by the short survival time, which did not allow the typical pathological 
signs in the according organs to develop.  
 
9.13 Prognostic indexes 
 
Coarse scoring methods can be used for predicting patient outcome or as a triage 
system (Tobiasen et al. 1982, Krob et al. 1991). Outcome from severe burn is 
associated with three major risk factors for death: age  ≥60 years, ≥%TBSA 40%, 
and presence of inhalation injury (Ryan et al. 1998, Brusselaers et al. 2005, Andel 
et al. 2007). These factors are taken into consideration when terminal care 
decisions are made. Study IV confirmed that age and %TBSA were linked to both 
short-term and long-term survival. We did not, however, find a connection between 
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inhalation injury and survival during 2006-2011. Nevertheless, in 1995-2005 
smoke inhalation injury was more common in the terminal care group than in the 
active care group (44% vs. 23%). 
 
We found in study IV that patient’s survival is mostly affected by age and %TBSA. 
As Baux value consists of %TBSA and age (Tobiasen et al. 1982), this study shows 
that Baux still has value as the first estimate of patients’ chances of survival. The 
ABSI values takes into account age, gender, %TBSA, full-thickness burn, and 
inhalation injury (Andel et al. 2007). This study was able to demonstrate the effects 
of %TBSA and age, and also gender in a long term, but not the effects of inhalation 
injury. The results of this study are in accordance with the ABSI scoring system as 
related to the threat to life (Andel et al 2007). 
 
Patients treated by physicians were more severely injured than patients treated by 
paramedics, as reflected by %TBSA and ISS. In Study IV, the first %TBSA 
estimation was performed on the scene in 54% of the cases. When the estimation 
was performed, the median difference between the pre-hospital and final estimates 
was only 3%. 
 
Statistically short term survival was affected with SpO2 values (99 for survivals 
and 98 for non- survivals), from a clinical point of view, there is no relevant 
difference between these values. Statistically long term survival was affected with 
first pre-hospital systolic blood pressure (for 30 day survival) and first in-hospital 
systolic blood pressure (for 6 month survival). These values were 116 mmHg for 
non-survivors in both groups, 132 mmHg for 30-days survivors, and 144 mmHg 
for 6-months survivors. Again, clinically there is no relevant difference between 
these values. 
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In a burn trauma, females have higher mortality than males (O'Keefe et al. 2001, 
McGwin et al. 2002). This has also been taken into consideration in the 
Abbreviated Burn Severity Score, where female gender earns a point, and the 
higher the points, the worse the prognosis (Tobiasen et al. 1982, Brusselaers et al. 
2005, Andel 2007,). In this study, older age and female gender contributed to 
higher mortality. Older age was not an explanatory factor for female mortality. 
Increased female mortality was noted at 30 days and at 6 months after the accident, 
beyond the systemic perturbation period. Gender did not affect immediate mortality 
in our patients.  
 
Late AKI has considerably high mortality (Coca et al. 2007, Mosier et al. 2010). 
From the study population, the majority of active care patients died of MOF and all 
MOF patients had AKI. This confirms the previous finding of potential lethality of 
AKI. But as it is unknown in this study population how many surviving patients 
had AKI, no conclusion can be drawn from this study material on the subject of 
withholding care based on patients AKI diagnosis.  
 
9.14 Limitations of the study 
 
This study has two fundamental limitations: its retrospective nature and the 
relatively small number of patients. 
 
As data in a retrospective study setting are not originally produced for 
investigational purposes, the data sheets are not always uniform, nor is the data 
reported in a consistent manner. This problem leads to missing values. Also 
investigator bias might develop when clinical impressions are gathered from 
medical records and compared to postmortem findings.  
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Interpretational bias was minimized by using a group of specialists (plastic 
surgeons, a pathologist, and an intensivist) to evaluate the data and by reviewing all 
of the cases in one session consecutively and comparing each case with itself and to 
all cases.  
 
The definition of MOF in this study was based on three or more organ failures 
noted clinically or as an autopsy finding. This definition is our own, and not used 
as such in any other studies, therefore direct comparison to other MOF studies 
might be biased.  
 
The number of patients in this study is quite small: 71 patients during 1995-2005 
and 67 patients during 2006-2011. The relatively low number of patients places its 
own limitation on the statistical analysis of the data. The low number is explained 
by Finland’s rather small population, 5 401 267 in habitants at the end of the year 
2011 (Tilastokeskus, http://www.stat.fi/til/vaerak/index.html), the rarity of severe 
burns in the Helsinki region, and the low overall mortality to burn injuries.  
 
In the study period from 2006 to 2010, documentation was done by either a 
paramedic or a physician. The documentation requirements are the same for 
physicians and paramedics, but we cannot rule out the possibility that physicians 
document data better than paramedics - or vice versa. Most importantly, as the 
study was observational, the formation of patient groups was not random. This 
non-random formation of groups led to profound bias regarding injury severity. 
Thus, the patient groups could not be directly compared.  
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9.15 Strengths of autopsies 
 
The autopsy rate in this study was 100%. This autopsy rate is very high compared 
with other studies in adult ICU settings, with autopsy rates ranging from 33 to 89% 
(Nadrous et al. 2003, Silfvast et al. 2003, Combes et al. 2004) and slightly higher 
than in the study by Fish et al. (Fish et al. 2000). The low autopsy rate in other 
studies might have led to selection bias, preferring cases in which physicians and 
family members of patients with premortem diagnostic uncertainty would have 
been more likely to pursue an autopsy than cases in which all parties were certain 
of the diagnoses and the outcome was predictable. 
 
A retrospective study allows maximal information to be gained on the course of 
events and the causes of death. Medicolegal autopsy reports provide 
uncompromisingly detailed information on cause of death, affected organs, and 
previous illnesses of the patient. Autopsy remains an invaluable tool for 
retrospective diagnostic understanding of difficult cases, medical education, and 
quality assurance in burn units. 
 
9.16 Future prospects 
 
It would be interesting to repeat this study setting every 10 years. Special points of 
interest would be if the overall mortality rate and number of terminal care patients 
decline as burn care advances. Would diagnostic discrepancies diminish as clinical 
diagnostics advance? It would be expected that over the years the severity of 
injuries in the deceased would increase. From this data, or the future data, it would 
be fascinating to identify the bacteria causing sepsis with MOF. Are some bacteria 
more lethal in burns than others? Have all the deceased MOF patients with sepsis 
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received the same antibiotics? Furthermore, it would be interesting to compare the 
autopsy findings of burn patients found dead on-the scene with patients who 
survived to hospital. Is it always carbon monoxide poisoning that kills in fires or 
are there other explanations for why people remain in the fire. The organ failures 
most commonly noted at deceased MOF patients were: acute kidney injury, acute 
liver injury, sepsis, pneumonia, and ARDS. Studies in search of the most effective 
diagnosis and care for these organ failures could improve the survival of burn 
patients. As increasingly more people survive burn traumas, it would be useful to 
examine the quality of life after a burn trauma and the effect of different 
treatments.  
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10 SUMMARY AND CONCLUSIONS 
 
Based on the present study, the following conclusions can be drawn: 
 
1) The mortality of a burn patient is associated with patient’s age, %TBSA, 
and ISS. In the long term, female gender predicted higher mortality.  
 
2) The incidence of bilateral adrenal hemorrhage is higher than previously 
published. Resuscitation unresponsive to vasoactive medication should 
raise the question of bilateral AH. 
 
3) Burn patient’s main causes of death in the ICU setting are burn injury itself 
and multiple organ failure. Kidneys were affected in every deceased MOF 
patient. Sepsis was always associated with MOF as a cause of death. The 
signs of sepsis should lead to careful organ monitoring in attempt to avoid 
MOF. 
 
4) Autopsies revealed some major clinical diagnostic discrepancies. Only 
5.6% of deceased burn patients had major diagnostic discrepancies that 
would have altered the clinical therapy or outcome had they been known in 
time. 
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